Document:

exv10w1

Exhibit 10.1

THIS DOCUMENT CONSTITUTES PART OF A PROSPECTUS COVERING SECURITIES THAT HAVE BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933.

<<Letter Date>>

CONFIDENTIAL TO: <<Name>>

In the meeting on <<Meeting Date>>, you were granted Performance Units under the
Steelcase Inc. Incentive Compensation Plan (the “Plan”), subject to the terms and execution of this
Award Agreement.

This Award Agreement provides additional information regarding your Award and your rights under the
Plan. A copy of the Plan has already been provided to you. If there is any inconsistency between
this Award Agreement and the Plan, the Plan controls. Capitalized terms used in this Award
Agreement are defined in the Plan, unless defined herein.

Overview of Your Award

	 	1.	 	Type of Award: Performance Units as authorized under Article 9 of the Plan.
	 
	 	2.	 	Target Number of Performance Units under this Award, as may be increased from time to
time pursuant to paragraph 9C below (the “Target Award”): <<# of Performance
Units>>.
	 
	 	3.	 	Award Date: <<Award Date>>
	 
	 	4.	 	Performance Measure: Total Shareholder Return (“TSR”) during the three-year
Performance Period, as outlined in Article 12 of the Plan. For purposes of this Award,
TSR shall be expressed as a compound annual growth rate.
	 
	 	5.	 	Performance Period: The Performance Period for this Award begins on the first day of
the Company’s 2011 fiscal year and ends on the last day of the Company’s 2013 fiscal year.
	 
	 	6.	 	Number of Performance Units Earned:

	 	A.	 	Total Number of Performance Units Earned
	 
	 	 	 	Except as may be provided in paragraph 7 below, after completion of the Performance
Period, the total number of Performance Units will be earned and vested based
entirely on Relative TSR as of the last day of the Performance Period (the “Total
Award”). For purposes of the Total Award, TSR shall be expressed as a compound
annual growth rate and calculated as follows:

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 	 	 	(1/3)
	 	 
	 

	 	TSR
	 	=
	 	(
	 	Ending Stock Price + Dividends Paid
 

	 	 	)	 	 
	- 1	 
	 

	 	 	 	 	 	 	Beginning Stock Price	 	 	 	 	 	 

	 	 	 	“Beginning Stock Price” shall mean the average closing price as reported on the New
York Stock Exchange (or such other principal exchange as the Company’s Class A
Common Stock may be traded from time to time) of one (1) Share for the twenty (20)
trading days immediately prior to the first day of the Performance Period. “Ending
Stock Price” shall mean the average closing 

 

 

	 	 	 	price as reported on the New York Stock Exchange (or such other principal exchange as the
Company’s Class A Common Stock may be traded from time to time) of one (1) Share for
the last twenty (20) trading days of the Performance Period. “Dividends Paid” shall
include all dividends paid as described in paragraph 9 of this Award Agreement.
	 
	 	 	 	To determine Relative TSR, a Peer Group of companies approved by the Committee will
be used. The Peer Group will be ranked from highest Total Shareholder Return
expressed as a compound annual growth rate to lowest Total Shareholder Return
expressed as a compound annual growth rate. The total number of Performance Units
earned and vested as of the last day of the Performance Period based upon Relative
TSR shall then be determined by comparing the Company’s TSR expressed as a compound
annual growth rate to the Peer Group and based upon the following chart.
Interpolation shall be used in the event the Company’s percentile rank does not fall
directly on one of the ranks listed in the table below and in no event will the
payout as a percent of the Target Award exceed 200%.

	 	 	 	 	 
	 	 	Total Number of Performance Units as
	Relative TSR	 	a Percent of Target Award
	90th Percentile and above
	 	 	200	%
	80th Percentile
	 	 	175	%
	70th Percentile
	 	 	150	%
	60th Percentile
	 	 	125	%
	50th Percentile
	 	 	100	%
	40th Percentile
	 	 	75	%
	30th Percentile
	 	 	50	%

	 	B.	 	Minimum Number of Performance Units Earned
	 
	 	 	 	Notwithstanding paragraph 6A above, and except as may be provided in paragraphs 7
and 9C below, <<#=25% of Target Award>> Performance Units which is 25%
of your Target Award, rounded down to the nearest whole Share (the “Floor Award”),
will become earned and vested under this Agreement if you remain employed by the
Company or an Affiliate through the last day of the Performance Period whether or
not any of the performance criteria set forth in paragraph 6A above are met.
	 
	 	C.	 	TSR Award
	 
	 	 	 	Any Performance Units in excess of the Floor Award shall be referred to as the “TSR
Award”.

	 	7.	 	Death, Disability, Retirement Eligibility, Termination without Cause or Change in
Control :

	 	A.	 	Death or Disability
	 
	 	 	 	If you die or become Disabled while an Employee after <<Award Date + 6
months>> during the Performance Period,
	 
	 		 	(i) your Floor Award will become immediately fully vested; and
	 
	 		 	(ii) all or a portion of your TSR Award will become immediately earned and vested in
accordance with the following schedule:

	 	•	 	If you die or become Disabled after <<Award Date + 6 months>>
through the last day of the Company’s 2011 fiscal year, one-third of your TSR
Award will become earned and vested;

 

 

	 	•	 	If you die or become Disabled during the Company’s 2012 fiscal year,
two-thirds of your TSR Award will become earned and vested;
	 
	 	•	 	If you die or become Disabled during the Company’s 2013 fiscal year, your
entire TSR Award will become earned and vested.

	 	 	 	A “Disability” or “become Disabled” means that, by reason of any medically
determinable physical or mental impairment that can be expected to result in death
or can be expected to last for a continuous period of not less than twelve months,
you are unable to engage in any substantial gainful activity or are receiving income
replacement benefits under an accident and health plan covering employees of the
Company for a period of not less than three months.

	 	B.	 	Retirement Eligibility
	 
	 	 	 	In the event you become Retirement Eligible during the Performance Period,
	 
	 		 	(i) your Floor Award will become immediately fully vested and the Company will issue
you corresponding Shares as soon as practicable following the last day of the
Performance Period (and not when you become Retirement Eligible or on your date of
Retirement), but in no event more than 90 days following the last day of the
Performance Period; and
	 
	 		 	(ii) you will continue to be eligible to earn and vest your TSR Award in accordance
with paragraph 6 of this Award Agreement.
	 
	 	 	 	“Retirement Eligible” means your age plus years of continuous service total 80 or
more and “Retirement” means your employment is terminated following becoming
Retirement Eligible.
	 
	 	C.	 	Termination without Cause
	 
	 	 	 	Except as provided in paragraph 7B, if you are terminated without Cause by the
Company or the Affiliate then employing you (a “Termination without Cause”) during
the Performance Period,
	 
	 		 	(i) your Floor Award will become immediately fully vested; provided, that
such termination of employment constitutes a “separation from service” under Section
409A of the Code; and
	 
	 		 	(ii) your TSR Award will be forfeited in its entirety.
	 
	 	 	 	The term “Cause” means (1) your willful and continued failure to perform
substantially your duties with the Company or the Affiliate then employing you
(other than any such failure resulting from incapacity due to physical or mental
illness), or (2) your willful engaging in illegal conduct or gross misconduct that
is materially and demonstrably injurious to the Company; provided, that for
purposes of this definition, no act or failure to act, on your part, will be
considered “willful” unless it is done, or omitted to be done, by you in bad faith
or without reasonable belief that your action or omission was in the best interests
of the Company or the Affiliate then employing you.
	 
	 	 	 	For the avoidance of doubt, if you are terminated without Cause and you are
Retirement Eligible, then the terms of your Award will be governed by paragraph 7B.
	 
	 	D.	 	Change in Control
	 
	 	 	 	In the event of a Change in Control after <the Award Date+ 6 months> during
the Performance Period,
	 
	 		 	(i) your Floor Award will become immediately fully vested; and

 

 

	 		 	(ii) you will become immediately earned and vested in a pro-rata portion of your TSR
Award based on the Total Award being equal to the Target Award and based upon the
portion of the Performance Period which has elapsed prior to the Change in Control.
	 
	 	 	 	Notwithstanding anything to the contrary, if the Change in Control event does not
constitute a change in ownership or effective control of the Company or a change in
ownership of a substantial portion of the assets of the Company under Section 409A
of the Code, and if the Company determines your Floor Award constitutes deferred
compensation subject to Section 409A of the Code, then the Company will issue you
the Shares underlying your Floor Award as soon as practicable following the last day
of the Performance Period (and not upon the Change in Control), but in no event more
than 90 days following the last day of the Performance Period.

	 	8.	 	Payment

	 	A.	 	Floor Award
	 
	 	 	 	Except as may be provided in paragraphs 7B or 7D, your Floor Award will be paid to
you in Shares as soon as administratively practicable, but in no event later than 90
days following the date of vesting.
	 
	 	B.	 	TSR Award
	 
	 	 	 	Your TSR Award, if any, will be paid to you in Shares, rounded down to the nearest
whole Share, as soon as administratively practicable following the date of vesting,
but in no event later than 2 1/2 months following the end of the calendar year in
which vesting occurs.
	 
	 	C.	 	Maximum Payout Under the Plan
	 
	 	 	 	Notwithstanding any provision under this Award Agreement and in accordance with the
terms of the Plan, your maximum aggregate payout (determined as of the last day of
the Performance Period) in any one fiscal year will be either:
	 
	 		 	(i) equal to 200% of the Target Award in the event that the shareholders of the
Company approve the Plan as amended and restated at the 2010 Meeting, or
	 
	 		 	(ii) equal to 200% of the Target Award, but in no event more than two hundred fifty
thousand (250,000) Shares in the event that the shareholders of the Company do not
approve the Plan as amended and restated at the 2010 Meeting.

	 	9.	 	Voting Rights and Dividend-Equivalents:

	 	A.	 	No Voting Rights
	 
	 	 	 	You are not the owner of record of the Shares underlying your Performance Units
until the applicable Transfer Date (as defined in this paragraph) and accordingly,
you will have no voting rights on such Shares. In all cases, the date the Shares
are issued to you with respect to your Floor Award or TSR Award is referred to as
the “Transfer Date”.
	 
	 	B.	 	Cash Dividend-Equivalents
	 
	 	 	 	You will receive a cash payment equal to any cash dividends that the Company
declares and pays on its Shares with respect to the number of Shares underlying your
Target Award. The Company
shall pay such cash dividend-equivalents at such time or times as it determines in
its sole

 

 

	 	 	 	discretion; provided, the Company shall pay any cash
dividend-equivalent within the calendar year in which the cash dividend is paid to
shareholders.
	 
	 	C.	 	Stock Dividend-Equivalents
	 
	 	 	 	You will be entitled to be credited with dividend-equivalents in the form of Shares
with respect to the number of Shares underlying your Target Award, calculated as
follows: on each date that a stock dividend is paid by the Company while your
Performance Units are outstanding, your Target Award will be increased with an
additional number of Performance Units equal to the number of whole Shares that
would have been issued with respect to your Target Award had the Performance Units
been issued as Shares. The additional Performance Units credited under this
paragraph will be subject to the same terms and conditions applicable to your
Performance Units originally granted under this Award Agreement, including, without
limitation, for purposes of crediting additional dividend-equivalents.

	 	10.	 	Forfeiture of Awards:
	 
	 	 	 	All unearned Performance Units will be forfeited upon a termination of your employment
during the Performance Period for any reason other than death, Disability, Retirement or a
Termination without Cause.
	 
	 	 	 	Any Performance Units that do not vest as a result of the events under paragraphs 6 or 7
shall be forfeited immediately upon the occurrence of such event.
	 
	 	 	 	Pursuant to Article 15.4 of the Plan, if you engage in any Competition with the Company (as
defined in the Plan and determined by the Administrative Committee in its discretion) you
will immediately and permanently forfeit the right to receive payment from this Award,
whether or not vested. You must return to the Company any gain resulting from this Award at
any time within the twelve-month period preceding the date you engaged in Competition with
the Company.
	 
	 	11.	 	Transfer: Performance Units may not be sold, transferred, pledged, assigned, or
otherwise alienated or hypothecated, other than by will or by the laws of descent and
distribution.
	 
	 	12.	 	Taxes: You may be required to pay to the Company or an Affiliate and the Company
and/or Affiliate shall have the right and are hereby authorized to withhold from any
payment due or transfer made under this Award or from any compensation or other amount
owing to you the amount (in cash, Shares, other securities or other property) of any
applicable withholding taxes in respect of this Award or any payment or transfer under or
with respect to this Award and to take such other action as may be necessary to satisfy
all obligations for the payment of such withholding taxes.
	 
	 	13.	 	Administration: This Award Agreement and your rights hereunder are subject to all
the terms and conditions of the Plan, as the same may be amended from time to time, as
well as to such rules and regulations as the Committee may adopt for administration of the
Plan. It is expressly understood that the Committee or its designee is authorized to
administer, construe, and make all determinations necessary or appropriate to the
administration of the Plan and this Award Agreement, all of which will be binding upon the
Participant.
	 
	 	14.	 	Required Approvals: This Award Agreement will be subject to all applicable laws,
rules and regulations, and to such approvals by any governmental agencies or national
securities exchanges as may be required.
	 
	 	15.	 	Governing Law: To the extent not preempted by federal law, this Award Agreement will
be governed by, and construed in accordance with, the laws of the State of Michigan, USA.
	 
	 	16.	 	Amendment: This Award Agreement may be amended or modified by the Committee as long
as the amendment or modification does not materially adversely affect your Award.
Notwithstanding anything to

 

 

	 	 	 	the contrary contained in the Plan or in this Award Agreement, to the extent that the
Company determines that the Performance Units are subject to Section 409A of the Code and
fail to comply with the requirements of Section 409A of the Code, the Company reserves the
right to amend, restructure, terminate or replace the Performance Units in order to cause
the Performance Units to either not be subject to Section 409A of the Code or to comply with
the applicable provisions of such section.
	 
	 	17.	 	Six-Month Delay of Payment: To the extent required in order to avoid accelerated
taxation and/or tax penalties under Section 409A of the Code, amounts that would otherwise
be payable and benefits that would otherwise be provided pursuant to this Award Agreement
during the six-month period immediately following your “separation from service” (as
defined under Section 409A of the Code) will instead be paid as soon as practicable
following the first business day after the date that is six months following your
separation from service (or death, if earlier), but in no event later than 30 days
following such date.

By signing this Award Agreement, you hereby acknowledge:

	(a)	 	that the Plan is discretionary in nature and may be suspended or terminated at any
time;
	 
	(b)	 	that each grant of a Performance Unit is a one-time benefit which does not create any
contractual or other right to receive future grants of Performance Units, or benefits
in lieu of Performance Units;
	 
	(c)	 	that all determinations with respect to future grants, if any, including, but not
limited to, the times when the Performance Units will be granted, the number of Shares
subject to each grant, and the time or times when each Share will vest, will be at the
sole discretion of the Board of Directors;
	 
	(d)	 	that your participation in the Plan does not create a right to further employment
with your employer and will not interfere with the ability of your employer to
terminate your employment relationship at any time with or without cause;
	 
	(e)	 	that your participation in the Plan is voluntary;
	 
	(f)	 	that the value of the Performance Units is an extraordinary item of compensation
which is outside the scope of your employment contract, if any;
	 
	(g)	 	that the Performance Units are not part of normal and expected compensation for
purposes of calculating any severance, resignation, redundancy, end of service
payments, bonuses, long-service awards, pension or retirement benefits or similar
payments;
	 
	(h)	 	that the right to the grant ceases upon termination of employment for any reason
except as may otherwise be explicitly provided in the Plan or this Award Agreement;
and
	 
	(i)	 	that the future value of the Performance Units is unknown and cannot be predicted
with certainty.

By signing this Award Agreement, and as a condition of the grant of the Performance Units, you
hereby consent to the collection, use and transfer of personal data as described below. You
understand that the Company and its subsidiaries hold certain personal information about you,
including, but not limited to, your name, home address and telephone number, email address, date of
birth, social security number, salary, nationality, job title, any Shares of stock or directorships
held in the Company, details of all Performance Units or other entitlement to Shares awarded,
canceled, exercised, vested, unvested or outstanding in your favor, for the purpose of managing and
administering the Plan (“Data”).

You further understand that the Company and/or its subsidiaries will transfer Data amongst
themselves as necessary for the purposes of implementation, administration and management of your
participation in the Plan, and that the Company and/or its subsidiaries may each further transfer
Data to any third parties assisting the Company in the implementation, administration and
management of the Plan (“Data Recipients”). You understand that these Data Recipients may be
located in your country of residence or elsewhere.

You hereby authorize the Data Recipients to receive, possess, use, retain and transfer Data in
electronic or other form, for the purposes of implementing, administering and managing your
participation in the Plan, including any transfer of such Data, as may be required for the
administration of the Plan and/or the subsequent holding of Shares on your behalf.

 

 

You understand that you may, at any time, review the Data, require any necessary amendments to it
or withdraw the consent herein in writing by contacting the Company. You further understand that
withdrawing consent may affect your ability to participate in the Plan and/or may affect your
Award.

If you have any questions regarding your Award or this Award Agreement, or would like a copy of the
Plan, please contact John Hagenbush, Director, Compensation, at (616) 246-9532.

Sincerely,

A

James P. Hackett

President and CEO

Please acknowledge your agreement to participate in the Plan and this Award Agreement, and to abide
by all of the governing terms and provisions, by signing the following representation. Your signed
representation must be returned by << 30 days after letter date>> to:

Compensation Department (CH-2E-04)

Attn: Nancy Kocsis

Steelcase Inc.

PO Box 1967

Grand Rapids, MI 49501-1967

Agreement to Participate

By signing a copy of this Award Agreement and returning it I acknowledge that I have read the Plan,
and that I fully understand all of my rights under the Plan, as well as all of the terms and
conditions that may limit my rights under this Award Agreement.

Date:     
                 
                
                
             
                
       

Participant:  
                
               
               
               
                

                
     <<Name>>exv10w1

EXHIBIT 10.1

 

 

Stock Purchase Agreement

Dated as of March 19, 2010

between

ION Geophysical Corporation

and

BGP Inc., China national Petroleum Corporation

 

Document No. 80961

 

 

 

 

TABLE OF CONTENTS

	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Page	 
	1.	 	Authorization of Sale of the Shares	 	 	1	 
	2.	 	Agreement to Sell and Purchase the Shares	 	 	1	 
	 
	 	2.1	 	Purchase and Sale	 	 	1	 
	 
	 	2.2	 	Purchase Price	 	 	1	 
	 
	 	2.3	 	Convertible Notes and Warrant	 	 	1	 
	3.	 	Delivery of the Shares at the Closing; Conditions to Obligations to Close; Termination	 	 	1	 
	 
	 	3.1	 	Closing	 	 	2	 
	 
	 	3.2	 	Simultaneous Closings	 	 	2	 
	 
	 	3.3	 	Closing Deliveries	 	 	2	 
	 
	 	3.4	 	Conditions to the Company’s Obligations	 	 	2	 
	 
	 	3.5	 	Conditions to the Purchaser’s Obligations	 	 	3	 
	 
	 	3.6	 	Conditions to Both Parties’ Obligations	 	 	5	 
	 
	 	3.7	 	Closing Date Shares	 	 	6	 
	 
	 	3.8	 	Termination	 	 	7	 
	 
	 	3.9	 	Effect of Termination	 	 	8	 
	4.	 	Representations, Warranties and Covenants of the Company	 	 	9	 
	 
	 	4.1	 	Organization and Qualification	 	 	9	 
	 
	 	4.2	 	Reporting Company; Form S-3	 	 	9	 
	 
	 	4.3	 	Authorized Capital Stock	 	 	9	 
	 
	 	4.4	 	Rights Agreement	 	 	10	 
	 
	 	4.5	 	Issuance, Sale and Delivery of the Shares	 	 	10	 
	 
	 	4.6	 	Due Execution, Delivery and Performance of this Agreement	 	 	10	 
	 
	 	4.7	 	Accountants	 	 	11	 
	 
	 	4.8	 	No Defaults or Consents	 	 	11	 
	 
	 	4.9	 	Contracts	 	 	12	 
	 
	 	4.10	 	No Actions	 	 	12	 
	 
	 	4.11	 	Properties	 	 	13	 
	 
	 	4.12	 	No Material Adverse Change	 	 	13	 
	 
	 	4.13	 	Intellectual Property	 	 	14	 

-i-

 

TABLE OF CONTENTS

(continued)

	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Page	 
	 
	 	4.14	 	Compliance	 	 	14	 
	 
	 	4.15	 	Taxes	 	 	15	 
	 
	 	4.16	 	Transfer Taxes	 	 	15	 
	 
	 	4.17	 	Investment Company	 	 	15	 
	 
	 	4.18	 	Securities Law Exemption	 	 	15	 
	 
	 	4.19	 	Insurance	 	 	15	 
	 
	 	4.20	 	Additional Information	 	 	15	 
	 
	 	4.21	 	Price of Common Stock	 	 	16	 
	 
	 	4.22	 	Use of Proceeds	 	 	17	 
	 
	 	4.23	 	References to the Purchaser	 	 	17	 
	 
	 	4.24	 	Related-Party Transactions	 	 	17	 
	 
	 	4.25	 	Off-Balance Sheet Arrangements	 	 	17	 
	 
	 	4.26	 	Governmental Permits, Etc	 	 	17	 
	 
	 	4.27	 	Financial Statements	 	 	17	 
	 
	 	4.28	 	Registration and Listing Compliance	 	 	18	 
	 
	 	4.29	 	Internal Accounting Controls	 	 	18	 
	 
	 	4.30	 	Foreign Corrupt Practices Act	 	 	19	 
	 
	 	4.31	 	Employee Relations	 	 	19	 
	 
	 	4.32	 	ERISA	 	 	19	 
	 
	 	4.33	 	Environmental Matters	 	 	20	 
	 
	 	4.34	 	Integration; Other Issuances of Shares	 	 	20	 
	 
	 	4.35	 	Disclosure	 	 	20	 
	 
	 	4.36	 	Authorization of the Investor Rights Agreement	 	 	20	 
	 
	 	4.37	 	Organization Documents	 	 	21	 
	5.	 	Representations, Warranties and Covenants of the Purchaser	 	 	21	 
	 
	 	5.1	 	Experience	 	 	21	 
	 
	 	5.2	 	Reliance on Exemptions	 	 	21	 
	 
	 	5.3	 	Investment Decision	 	 	22	 
	 
	 	5.4	 	Risk of Loss	 	 	22	 
	 
	 	5.5	 	Legend; Legend Removal	 	 	22	 

-ii-

 

TABLE OF CONTENTS

(continued)

	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Page	 
	 
	 	5.6	 	Organization; Validity; Enforcements	 	 	23	 
	 
	 	5.7	 	Authorization of the Investor Rights Agreement	 	 	24	 
	 
	 	5.8	 	Ownership of Common Stock; Filings by the Purchaser	 	 	24	 
	6.	 	Transfers; DTC	 	 	25	 
	 
	 	6.1	 	Transfers	 	 	25	 
	 
	 	6.2	 	DTC	 	 	25	 
	7.	 	Regulatory Matters	 	 	25	 
	 
	 	7.1	 	Further Assurances Regarding Regulatory Matters	 	 	25	 
	 
	 	7.2	 	Consultation	 	 	26	 
	 
	 	7.3	 	Furnishing of Information	 	 	26	 
	 
	 	7.4	 	Communications	 	 	26	 
	 
	 	7.5	 	Antitrust Filings	 	 	26	 
	 
	 	7.6	 	Avoidance of Impediments	 	 	27	 
	 
	 	7.7	 	No Substantial Detriment	 	 	27	 
	 
	 	7.8	 	CFIUS Filings	 	 	27	 
	8.	 	No New Issuances and Registrations	 	 	27	 
	9.	 	Registration of the Shares; Compliance with the Securities Act.	 	 	28	 
	 
	 	9.1	 	Registration	 	 	28	 
	 
	 	9.2	 	Transfer of Shares in Compliance with Securities Laws	 	 	28	 
	10.	 	Indemnification	 	 	28	 
	 
	 	10.1	 	Indemnification by the Company	 	 	28	 
	 
	 	10.2	 	Claims for Indemnification	 	 	29	 
	11.	 	Notification	 	 	30	 
	12.	 	Miscellaneous	 	 	30	 
	 
	 	12.1	 	Amendment and Waiver	 	 	30	 
	 
	 	12.2	 	No Waiver	 	 	30	 
	 
	 	12.3	 	Assignment	 	 	31	 
	 
	 	12.4	 	Parties in Interest; No Third Party Beneficiaries	 	 	31	 
	 
	 	12.5	 	Entire Agreement	 	 	31	 
	 
	 	12.6	 	Schedules	 	 	31	 

-iii-

 

TABLE OF CONTENTS

(continued)

	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Page	 
	 
	 	12.7	 	Counterparts	 	 	31	 
	 
	 	12.8	 	Section Headings	 	 	31	 
	 
	 	12.9	 	Notices	 	 	31	 
	 
	 	12.10	 	Dispute Resolution	 	 	32	 
	 
	 	12.11	 	GOVERNING LAW	 	 	33	 
	 
	 	12.12	 	Language	 	 	33	 
	 
	 	12.13	 	Severability	 	 	33	 
	 
	 	12.14	 	No Strict Construction	 	 	33	 
	 
	 	12.15	 	Survival	 	 	33	 
	 
	 	12.16	 	Fees and Expenses	 	 	33	 
	 
	 	12.17	 	Further Assurances	 	 	33	 
	 
	 	12.18	 	Publicity	 	 	34	 

-iv-

 

EXHIBITS

	 	 	 
	Exhibit A

	 	Investor Rights Agreement
	Exhibit B

	 	Forms of Legal Opinions of David L. Roland and Mayer Brown LLP
	Exhibit C

	 	List of Subsidiaries

SCHEDULES

Company Disclosure Schedule

	 	 	 
	Schedule 4.2

	 	Reporting Company; Form S-3
	Schedule 4.3

	 	Capital Structure
	Schedule 4.5

	 	Issuance, Sale and Delivery of the Shares
	Schedule 4.13

	 	Intellectual Property
	Schedule 4.14

	 	Compliance

-v-

 

Index of Defined Terms

	 	 	 	 	 
	Defined Term	 	Section
	1933 Act Rules and Regulations
	 	 	4.7	 
	1934 Act Rules and Regulations
	 	 	4.20	 
	Action
	 	 	4.10	 
	Additional Purchase Price
	 	 	3.7	(a)(ii)
	Affiliate
	 	 	4.23	 
	Agreement
	 	Introduction
	Antitrust Division
	 	 	7.5	 
	Bank of China
	 	 	1	 
	Beneficial Owner
	 	 	5.8	(a)
	Business Day
	 	 	2.3	 
	CFIUS
	 	 	3.6	(a)
	Closing
	 	 	3.1	 
	Closing Date
	 	 	3.1	 
	Closing Date Outstanding Shares
	 	 	3.5	(f)
	Code
	 	 	4.32	 
	Commission
	 	 	4.10	 
	Common Stock
	 	 	1	 
	Company
	 	Introduction
	Company Benefit Plan
	 	 	4.32	 
	Confidentiality Agreement
	 	 	3.9	 
	Convertible Notes
	 	 	1	 
	DTC
	 	 	5.5	(b)
	ERISA
	 	 	4.32	 
	Excess Shares
	 	 	3.7	(a)
	Exchange Act
	 	 	4.2	 
	Exon-Florio
	 	 	3.6	(a)
	FTC
	 	 	7.5	 
	Governmental Entities
	 	 	3.6	(b)
	HKIAC
	 	 	12.10	(a)
	HSR Act
	 	 	7.5	 
	Intellectual Property
	 	 	4.13	 
	JV
	 	 	3.2	(a)
	JV SPA
	 	 	3.2	(a)
	JV Transaction
	 	 	3.2	(a)
	Liens
	 	 	4.3	 
	Material Adverse Effect
	 	 	4.10	 
	Outside Date
	 	 	3.8	(b)
	Party or Parties
	 	Introduction
	Person
	 	 	4.23	 
	Pingpong Transactions
	 	 	3.2	 
	PRC
	 	Introduction
	Purchase Price
	 	 	2.2	 
	Purchaser
	 	Introduction

-vi-

 

	 	 	 	 	 
	Defined Term	 	Section	 
	Purchaser Indemnified Persons
	 	 	10	 
	Refinancing
	 	 	3.4	(d)
	Registration Statement
	 	 	9.1	(a)
	Required Approvals
	 	 	3.6	(b)
	Rights
	 	 	1	 
	Rights Agreement
	 	 	4.4	 
	Rights Preferred
	 	 	4.4	 
	Rule 144
	 	 	5.5	(a)
	Rules and Regulations
	 	 	4.20	 
	Sarbanes Oxley Act
	 	 	4.29	 
	SEC Documents
	 	 	4.20	 
	Securities Act
	 	 	3.3	 
	Shares
	 	 	1	 
	Stockholder Consents
	 	 	3.7	(a)(i)
	Subsequent Closing
	 	 	3.7	(b)
	Subsequent Closing Date
	 	 	3.7	(b)
	Subsidiary or Subsidiaries
	 	 	4.1	 
	Substantial Detriment
	 	 	3.6	(b)
	Transaction Term Sheet
	 	 	3.9	 
	Transfer
	 	 	6.1	 

Warrant 1

-vii-

 

     THIS STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of the 19th day
of March 2010, by and between ION Geophysical Corporation (the “Company”), a corporation
organized under the laws of the State of Delaware, and BGP Inc., China National Petroleum
Corporation (the “Purchaser”), a company organized under the laws of the People’s Republic
of China (the “PRC”). Each of the Company and the Purchaser is referred to herein as a
“Party” and collectively as “Parties”.

     IN CONSIDERATION of the representations and warranties and the mutual covenants contained in
this Agreement, the Company and the Purchaser agree as follows:

     1. Authorization of Sale of the Shares. Subject to the terms and conditions of this
Agreement, the Company has authorized the issuance and sale to the Purchaser of a certain number of
shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (the
“Common Stock”) and the preferred stock purchase rights appurtenant thereto (the
“Rights”) equal to (i) 23,789,536 (which is the number of Shares of the Company that is
equal to 19.99% of the Shares issued and outstanding as of October 21, 2009), minus (ii) the sum of
the number of shares of Common Stock (if any) issued upon (A) any exercises of the Warrant (as
defined below) and (B) any conversions of the Convertible Notes (as defined below).

     For purposes of this Agreement, (i) “Warrant” means that certain warrant issued by the
Company to the Purchaser pursuant to that certain Warrant Issuance Agreement, dated as of October
23, 2009, by and between the Company and the Purchaser and (ii) “Convertible Notes” means,
collectively, (A) that certain Convertible Promissory Note, dated October 23, 2009, issued by the
Company to the Bank of China, New York Branch (“Bank of China”), and (B) that certain
Convertible Promissory Note (Foreign Borrower), dated October 23, 2009, issued by ION International
S.à r.l., a Luxembourg private company, to Bank of China.

     2. Agreement to Sell and Purchase the Shares.

          2.1 Purchase and Sale. At the Closing (as defined in Section 3), the Company
will, subject to the terms of this Agreement, issue and sell to the Purchaser and the Purchaser
will buy from the Company, upon the terms and conditions hereinafter set forth, the Shares for the
consideration specified in Section 2.2.

          2.2 Purchase Price. The Purchaser agrees to pay to the Company at the Closing an
aggregate purchase price for the Shares (the “Purchase Price”) equal to the product of (i)
the number of Shares calculated pursuant to Section 1, multiplied by (ii) US$2.80 per
Share, by delivery of immediately available funds by wire transfer.

          2.3 Convertible Notes and Warrant. At least three (3) Business Days prior to the
Closing, the Purchaser shall deliver a notice to the Company setting forth its intent with respect
to its conversion or repayment of the Convertible Notes and/or a notice setting forth whether the
Purchaser will exercise the Warrant. The term “Business Day” for purposes of this
Agreement shall mean any day except a Saturday, Sunday or any other day on which commercial banks
in the U.S. or the PRC are required or authorized by Law to close.

- 1 -

 

     3. Delivery of the Shares at the Closing; Conditions to Obligations to Close;
Termination.

          3.1 Closing. The completion of the purchase and sale of the Shares (the
“Closing”) shall take place, subject to the satisfaction or waiver of all conditions to the
Closing set forth in Sections 3.3, 3.4 and 3.5, at the offices of Sullivan
& Cromwell LLP, Suite 501, China World Trade Center Tower 1, One Jianguo Menwai Avenue, Beijing,
PRC, at 10:00 a.m., on a date jointly designated by the parties hereto, which shall not be later
than ten (10) Business Days following the first date on which all conditions set forth in
Sections 3.3, 3.4 and 3.5 have been satisfied or waived (other than those
conditions that by their nature are to be satisfied by actions taken at the Closing) (such a date,
the “Closing Date”); provided that the Closing Date shall not be later than March
31, 2010.

          3.2 Simultaneous Closings. The Parties acknowledge and agree that the transactions
contemplated by this Agreement are an integral part of the transactions contemplated by the Parties
and that, each of the following shall be consummated simultaneously with the Closing (collectively
with the transactions contemplated hereby, the “Pingpong Transactions”):

     (a) the consummation of the sale by the Company of a 51% equity interest of the
subsidiary of the Company (the “JV”) to the Purchaser, as described in that
certain Share Purchase Agreement dated as of the date hereof (the “JV SPA”)
and the consummation of the other transactions contemplated by the JV SPA, including
the other Transaction Documents (as defined in the JV SPA) (collectively, the
“JV Transaction”);

     (b) the conversion in whole or in part of the Convertible Notes and/or the
exercise in whole or in part of the Warrant pursuant to their respective terms; and

     (c) the consummation of the Refinancing (as defined below).

          3.3 Closing Deliveries. At the Closing, the Purchaser shall deliver, in immediately
available funds, the full amount of the Purchase Price by wire transfer to an account designated by
the Company and the Company shall deliver to the Purchaser one or more stock certificates
registered in the name of the Purchaser, or in such nominee name(s) as designated by the Purchaser
in writing, evidencing the number of Shares as determined pursuant to Section 1 above
(along with certificate(s) evidencing the Shares acquired pursuant to Section 3.2(b) upon
conversion of the Convertible Notes and and/or any exercise of the Warrant) and bearing an
appropriate legend referring to the fact that the Shares were sold in reliance upon the exemption
from registration under the Securities Act of 1933, as amended (the “Securities Act”),
provided by Section 4(2) thereof and Rule 506 thereunder.

          3.4 Conditions to the Company’s Obligations. The Company’s obligation to complete the
sale of the Shares and deliver such stock certificate(s) to the Purchaser at the Closing shall be
subject to the following conditions (which may be waived in writing by the Company):

- 2 -

 

     (a) receipt by the Company, at the Closing, of same-day funds in the full
amount of the Purchase Price (along with funds representing the exercise price with
respect to any exercise of the Warrant pursuant to Section 3.2(b));

     (b) the accuracy of each of the representations and warranties made by the
Purchaser as of the date hereof and as of the Closing Date (except to the extent
that any such representation or warranty expressly speaks as of an earlier or later
date, in which case such representation and warranty shall be accurate as of such
earlier or later date) and the fulfillment in all material respects of those
undertakings of the Purchaser to be fulfilled prior to the Closing;

     (c) on or prior to the Closing Date, certain commercial lender(s) procured by
the Purchaser shall have entered into a new revolving line of credit with the
Company in the amount of US$100 million;

     (d) on or prior to the Closing Date, certain commercial lender(s) procured by
the Purchaser shall have refinanced the Company’s currently existing approximately
US$110.8 million term A loan (together with the transactions set forth in
Section 3.4(c), the “Refinancing”);

     (e) the Purchaser shall have, prior to or contemporaneously with the Closing
under this Agreement, completed (i) the contribution of certain of its assets to the
entity that will comprise the JV and the purchase of a 51% equity interest pursuant
to the JV SPA and (ii) the transactions to be performed by the Purchaser related
thereto at or prior to the Closing as described in the JV SPA; and

     (f) on the Closing Date, the Purchaser shall have duly executed and delivered
to the Company an Investor Rights Agreement in substantially the form set forth as
Exhibit A hereto (the “Investor Rights Agreement”), which when
effective shall replace, and cause to be terminated, that certain Registration
Rights Agreement, dated as of October 23, 2009, between the Company and the
Purchaser.

          3.5 Conditions to the Purchaser’s Obligations. The Purchaser’s obligation to accept
delivery of such stock certificate(s) and to pay the Purchase Price for the Shares evidenced
thereby shall be subject to the following conditions (which may be waived in writing by the
Purchaser):

     (a) the accuracy of each of the representations and warranties made by the
Company as of the date hereof and as of the Closing Date (except to the extent that
any such representation or warranty expressly speaks as of an earlier or later date,
in which case such representation and warranty shall be accurate as of such earlier
or later date) and the fulfillment in all material respects of those undertakings of
the Company to be fulfilled prior to the Closing;

     (b) the delivery to the Purchaser legal opinions substantially similar in
substance to the forms of opinions attached as Exhibit B hereto by (i) David
L.

- 3 -

 

Roland, Esq., Senior Vice President, General Counsel and Corporate Secretary of
the Company, and (ii) Mayer Brown LLP, outside securities counsel to the Company;

     (c) receipt by the Purchaser of a certificate executed by the chief executive
officer and the chief financial or accounting officer of the Company, dated as of
the Closing Date, to the effect that (i) the representations and warranties of the
Company set forth herein are true and correct as of the date of this Agreement and
as of the Closing Date and (ii) the Company has complied with all the agreements and
satisfied all the conditions herein on its part to be performed or satisfied on or
prior to the Closing Date without violating its Restated Certificate of
Incorporation or its Amended and Restated Bylaws;

     (d) receipt by the Purchaser of a certificate of the Secretary of the Company,
dated as of the Closing Date:

     (i) certifying the resolutions adopted by the Board of Directors of
the Company approving the transactions contemplated by this Agreement,
including the issuance of the Shares, and under the Pingpong
Transactions;

     (ii) certifying the current versions of the Restated Certificate of
Incorporation and the Amended and Restated Bylaws of the Company; and

     (iii) certifying as to the signatures and authority of the Persons
signing this Agreement and related documents on behalf of the Company;

     (e) receipt by the Purchaser of a certificate of good standing for the Company
for its jurisdiction of incorporation and a certificate of qualification as a
foreign corporation for the Company for any jurisdictions in which it is qualified
to transact business as a foreign corporation;

     (f) receipt by the Purchaser, at the Closing, of a certificate from the
Company’s transfer agent certifying as to the number of shares of Common Stock
outstanding as of the close of business on the last Business Day preceding the
Closing Date (the “Closing Date Outstanding Shares”);

     (g) there shall have been no suspensions in the trading of the Common Stock as
of the Closing Date;

     (h) on the Closing Date, the Company shall have duly executed and delivered to
the Purchaser the Investor Rights Agreement;

     (i) the Shares shall have been duly authorized for listing on The New York
Stock Exchange, subject only to official notice of issuance; and

- 4 -

 

     (j) the Company shall have, prior to or contemporaneously with the Closing
under this Agreement, (1) fulfilled all its obligations and taken all actions
necessary to complete the Restructuring (as set forth in Section 5.7 of the JV SPA)
and (2) completed the transactions to be performed by the Company at or prior to the
Closing as part of the JV Transaction.

          3.6 Conditions to Both Parties’ Obligations. The respective obligations of the
Purchaser and the Company to consummate the transactions contemplated in this Agreement shall be
subject to the following mutual conditions:

     (a) (i) The Committee on Foreign Investment in the United States
(“CFIUS”) shall have provided notice to the Parties to the effect that a
review or investigation of the transactions contemplated by this Agreement has been
concluded, and that a determination has been made that the transaction is not a
covered transaction subject to CFIUS review or (ii) the period of time for any
applicable review process by CFIUS and any subsequent Presidential decision whether
to take action under the Exon-Florio Provision of the Defense Production Act of
1950, 50 U.S.C. app. § 2170, as amended (“Exon-Florio”) shall have expired,
and the President of the U.S. shall not have taken action to block or prevent the
consummation of the transactions contemplated by this Agreement under Exon-Florio on
the basis that they threaten to impair the national security of the United States or
otherwise;

     (b) the approvals or authorizations of, filings and registrations with, and
notifications to, all governmental or regulatory authorities (collectively,
“Governmental Entities”) required for the Purchaser’s acquisition of the
Shares (collectively, the “Required Approvals”) shall have been obtained or
made and shall be in full force and effect and all waiting periods under the
Required Approvals shall have expired or been terminated, in each case without the
imposition of any procedural or substantive requirement, term, condition or
consequence the acceptance of which would materially adversely alter (A) the
Purchaser’s or any of its Affiliates’ (as defined in Section 4.23) ability
to own or operate any of their respective businesses or operations or ability to
conduct any such businesses or operations substantially as conducted as of the date
of this Agreement, (B) the Company’s or any of its Affiliates’ ability to own or
operate any of their respective businesses or operations or ability to conduct any
such businesses or operations substantially as conducted as of the date of this
Agreement or (C) the Purchaser’s ability to acquire, hold and dispose of the Shares
(or vote the Shares) and realize the economic incidents of ownership of such Shares
(any such alteration being referred to above in this Section 3.6(b) as a
“Substantial Detriment”), and no provision of any applicable law or
regulation, judgment, injunction, order or decree shall be in effect that would
prohibit the Closing, and no Governmental Entity shall have instituted an
investigation or proceeding that could result in such a judgment, injunction, order
or decree; and

     (c) without limiting the generality of Section 3.6(b), without any
Substantial Detriment, all filings required under the HSR Act (as defined in

- 5 -

 

Section 7.5) with respect to the transactions contemplated by this
Agreement shall have been made and any required waiting period (and any extensions
thereof) under the HSR Act applicable to the transactions contemplated by this
Agreement shall have been terminated without action by the Antitrust Division (as
defined in Section 7.5) or the FTC (as defined in Section 7.5) to
prevent consummation of the transactions contemplated by this Agreement.

          3.7 Closing Date Shares.

     (a) The Purchaser and the Company acknowledge and agree that if on the Closing
Date the number of shares of Common Stock representing 19.99% of the Closing Date
Outstanding Shares exceeds 23,789,536 by 1,000,000 or more shares (such excess
shares of Common Stock, the “Excess Shares”), then the Purchaser shall have
the right but not the obligation to:

     (i) require the Company to use the Company’s reasonable best efforts
to obtain all Required Approvals and all applicable requisite consents,
approvals or ratifications of the stockholders of the Company
(“Stockholder Consents”) in connection with the issuance and sale
of such Excess Shares (and immediately following the exercise of such
right, the Company shall take all actions, necessary or advisable for
securing such Required Approvals and Stockholder Consents); and

     (ii) subject to the receipt of such Required Approvals and
Stockholder Consents as set forth in Section 3.7(a)(i), require
the Company to issue and sell to the Purchaser such Excess Shares and
associated Rights for a consideration equal to $2.80 multiplied by the
number of such Additional Shares (such amount, the “Additional
Purchase Price”), all pursuant to and in accordance with the terms
and conditions of this Agreement.

     (b) On a date and time mutually agreed upon by the Parties (the “Subsequent
Closing Date”) that shall occur within five (5) Business Days after the Company
has received all such Required Approvals and Stockholder Consents, the closing of
the exercise by the Purchaser of its rights to purchase such Excess Shares (the
“Subsequent Closing”) shall take place at the offices of Sullivan & Cromwell
LLP, Suite 501, China World Trade Center Tower 1, One Jianguo Menwai Avenue,
Beijing, PRC. At the Subsequent Closing, the Purchaser shall deliver, in
immediately available funds, the full amount of the Additional Purchase Price by
wire transfer to an account designated by the Company and the Company shall deliver
to the Purchaser one or more stock certificates registered in the name of the
Purchaser, or in such nominee name(s) as designated by the Purchaser in writing,
evidencing the number of Excess Shares and bearing an appropriate legend referring
to the fact that the Shares were sold in reliance upon the exemption from
registration under the Securities Act provided by Section 4(2) thereof and Rule 506
thereunder. In addition, at the Subsequent Closing

- 6 -

 

     (i) the Company shall deliver to the Purchaser a certificate
executed by the chief executive officer and the chief financial or
accounting officer of the Company, dated as of the Subsequent Closing
Date, to the effect that (A) the representations and warranties of the
Company set forth herein are true and correct as of the Subsequent
Closing Date (except to the extent that any such representation or
warranty expressly speaks as of a specified date, in which case such
representation and warranty shall be accurate as of such specified date)
and (B) the Company has satisfied all the conditions herein on its part
to be performed or satisfied on or prior to the Subsequent Closing Date
without violating its Restated Certificate of Incorporation or its
Amended and Restated Bylaws, and the Excess Shares have been duly
authorized for listing on The New York Stock Exchange, subject only to
official notice of issuance;

     (ii) the Company shall deliver to the Purchaser legal opinions
substantially similar in substance to the forms of opinions attached as
Exhibit B hereto by (i) David L. Roland, Esq., Senior Vice
President, General Counsel and Corporate Secretary of the Company, and
(ii) Mayer Brown LLP, outside securities counsel to the Company with
respect to such Additional Shares; and

     (iii) the Purchaser shall deliver to the Company a certificate
executed by an authorized officer of the Company, dated as of the
Subsequent Closing Date, to the effect that (A) the representations and
warranties of the Purchaser set forth herein are true and correct as of
the Subsequent Closing Date (except to the extent that any such
representation or warranty expressly speaks as of a specified date, in
which case such representation and warranty shall be accurate as of such
specified date) and (B) the Company has satisfied all the conditions
herein on its part to be performed or satisfied on or prior to the
Subsequent Closing Date; and

     (iv) each of the Company and the Purchaser reaffirm their respective
representations and warranties as of the Subsequent Closing Date (except
to the extent that any such representation or warranty expressly speaks
as of an earlier or later date, in which case such representation and
warranty shall be accurate as of such earlier or later date) and reaffirm
that it has fulfilled in all material respects those undertakings of such
Party to be fulfilled prior to the Subsequent Closing.

          3.8 Termination. This Agreement may be terminated at any time prior to the Closing:

     (a) by the mutual written consent of the Purchaser and the Company.

- 7 -

 

     (b) by either the Purchaser or the Company giving notice of such termination to
the other if the Closing shall not have occurred by March 31, 2010 (the “Outside
Date”); provided, however, that the right to terminate this
Agreement under this Section 3.8(b) shall not be available to any Party
whose material breach of this Agreement, or whose failure to fulfill any obligation
under this Agreement, shall have been the cause of, or shall have resulted in, the
failure of a condition to the Closing to occur on or prior to such date;

     (c) by either the Purchaser or the Company in the event that any of the
conditions to the Parties’ obligations set forth in Section 3.6 have not
been satisfied on or before the Outside Date;

     (d) by either the Purchaser or the Company in the event that any other
Governmental Entity shall have issued an order, decree or ruling or taken any other
action restraining, enjoining or otherwise prohibiting the transactions contemplated
by this Agreement or any of the other Pingpong Transactions referred to in
Section 3.2 hereof, and such order, decree, ruling or other action shall
have become final and non-appealable;

     (e) by the Purchaser in the event that (i) the conditions to the Purchaser’s
obligations to close pursuant to Section 3.5 have not been satisfied or
waived on or before the Outside Date, or (ii) any event, condition or circumstance
shall have occurred or be existing that constitutes a Material Adverse Effect (as
that term is defined in Section 4.10 hereof), and such failure to perform,
breach, condition or circumstance is not cured within thirty (30) days following
written notice thereof from the Purchaser to the Company;

     (f) by the Company in the event that the conditions to the Company’s
obligations to close pursuant to Section 3.4 have not been satisfied or
waived on or before the Outside Date; or

     (g) automatically upon the termination of the JV SPA in accordance with its
terms.

          3.9 Effect of Termination. In the event of the termination of this Agreement by the
Purchaser or the Company pursuant to Section 3.8, written notice of termination shall be
given by the terminating Party to the other Party, and this Agreement shall, without further action
by either Party hereto, forthwith terminate and be rendered null and void and there shall be no
liability on the part of either Party hereto to the other Party or to its Affiliates, directors,
officers or employees, except (i) that nothing shall relieve either Party from liability for any
breach of this Agreement by such Party; (ii) for the Parties’ respective obligations under
Section 10,Section 12.9, Section 12.10, Section 12.11,
Section 12.15, Section 12.16 and Section 12.18; and (iii) the respective
rights and obligations of the Parties under that certain Non-Disclosure Agreement, dated as of
August 7, 2009 (the “Confidentiality Agreement”), shall continue in full force and effect
in accordance with its terms. Without limitation of the generality of any of the foregoing, upon
the termination of this Agreement, (i) any and all obligations of the Parties to negotiate,
discuss, communicate and deal exclusively with each other with regards to

- 8 -

 

contemplating any acquisition or purchase of any equity securities of the Company or any of
its Subsidiaries (other than pursuant to the Warrant or the Convertible Notes) or any of the
Company’s business segments or groups, or any contribution of properties and assets by the Parties
to (or any formation of) any joint venture or similar enterprise by and among the Parties and/or
their Affiliates contained in Article (F)(3) of the Term Sheet entered into by the Parties on
October 23, 2009 (the “Transaction Term Sheet”), shall thereupon be terminated,
extinguished and rendered null and void for all purposes whatsoever and neither Party shall
thereupon have any liability to the other Party with respect thereto.

     4. Representations, Warranties and Covenants of the Company. The Company hereby
represents and warrants to, and covenants with, the Purchaser as follows:

          4.1 Organization and Qualification. The Company is a corporation duly incorporated,
validly existing and in good standing under the laws of the State of Delaware, and the Company is
qualified to transact business as a foreign corporation in each jurisdiction in which qualification
is required, except where the failure to so qualify would neither have nor reasonably be expected
to have a Material Adverse Effect (as defined in Section 4.10 below). Each subsidiary (as
defined under Rule 405 promulgated under the Securities Act) of the Company (each, a
“Subsidiary” and collectively, the “Subsidiaries”) are listed on Exhibit C
to this Agreement. Each Subsidiary is a direct or indirect wholly owned subsidiary of the Company.
Each Subsidiary is duly organized, validly existing and in good standing under the laws of its
jurisdiction of organization and is qualified to transact business as a foreign corporation in each
jurisdiction in which qualification is required, except where failure to so qualify would neither
have nor reasonably be expected to have a Material Adverse Effect.

          4.2 Reporting Company; Form S-3. The Company is not an “ineligible issuer” (as
defined in Rule 405 promulgated under the Securities Act) and is eligible to register the resale of
the Shares by the Purchaser on a registration statement on Form S-3 under the Securities Act. The
Company is subject to the reporting requirements of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), and has filed all reports (including applicable exhibits thereto)
required thereby during the past three years. Provided that the Purchaser is not deemed to be an
underwriter with respect to any Shares and except as provided on Schedule 4.2 hereto, to
the Company’s knowledge, there exist no facts or circumstances (including without limitation any
required approvals or waivers or any circumstances that may delay or prevent the obtaining of
accountant’s consents) that reasonably could be expected to prohibit the preparation and filing of
a registration statement on Form S-3 that will be available for the resale of the Shares by the
Purchaser.

          4.3 Authorized Capital Stock. Set forth in Schedule 4.3 is the Company’s
capital structure as of the date hereof; the issued and outstanding shares of Common Stock (a) have
been duly authorized and validly issued, (b) are fully paid and nonassessable, (c) have been issued
in compliance with all federal and state securities laws and, (d) except for those granted therein
by the holders thereof (other than the Company), are free and clear of all security interests,
liens, pledges, mortgages or other encumbrances, whether arising voluntarily, involuntarily or by
operation of law (“Liens”), and (e) were not issued in violation of or subject to any
preemptive rights or other rights to subscribe for or purchase securities. Except as set forth in
Schedule 4.3 and except for the stock options or other equity incentives that have been

- 9 -

 

issued since March 1, 2010, the Company does not have outstanding any options to purchase, or
any preemptive rights or other rights to subscribe for or to purchase, any securities or
obligations convertible into, or any contracts or commitments to issue or sell, shares of its
capital stock or any such options, rights, convertible securities or obligations. With respect to
each of the Subsidiaries, (i) all of the issued and outstanding shares of such Subsidiary’s capital
stock (or equity interests in the case of non-corporate entities) have been duly authorized and
validly issued, are fully paid and nonassessable, have been issued in compliance with all federal
and state securities laws and were not issued in violation of or subject to any preemptive rights
or other rights to subscribe for or purchase securities and were not issued in violation of any
contract or agreement to which the Company is a party; and (ii) there are no outstanding options to
purchase, or any preemptive rights or other rights to subscribe for or to purchase, any securities
or obligations convertible into, or any contracts or commitments to issue or sell, shares of such
Subsidiary’s capital stock or any such options, rights, convertible securities or obligations. The
Company has no current plans or intentions to issue any additional shares of Common Stock between
the date hereof and the Closing, except for stock options or other equity incentives under the
Company’s existing employee benefit or compensation plans or Common Stock issued pursuant to the
conversion of other capital stock outstanding as of the date hereof, the conversion of the
Convertible Notes, the exercise of the Warrant or as otherwise contemplated in this Agreement.

          4.4 Rights Agreement. The Rights Agreement, dated as of December 30, 2008, between
the Company and Computershare Trust Company, N.A., as Rights Agent, (the “Rights
Agreement”), has been duly authorized, executed and delivered by the Company. The Rights have
been duly authorized by the Company and, when issued upon issuance of the Shares, will be validly
issued. The Series A Junior Participating Preferred Stock, par value $0.01 per share (the
“Rights Preferred”), has been duly authorized by the Company and validly reserved for
issuance. Upon the exercise of the Rights in accordance with the terms of the Rights Agreement,
the Rights Preferred, Common Stock or other securities issued pursuant to the Rights Agreement will
be validly issued, fully paid and non-assessable.

          4.5 Issuance, Sale and Delivery of the Shares. The issuance and sale of the Shares
have been duly authorized by the Company and the Shares, when issued, delivered and paid for in the
manner set forth in this Agreement, will be validly issued, fully paid and nonassessable. No
preemptive rights or other rights to subscribe for or purchase any shares of Common Stock of the
Company exist with respect to the issuance and sale of the Shares by the Company pursuant to this
Agreement that have not been waived or complied with. Except as set forth on Schedule 4.5,
no stockholder of the Company has any right (which has not been waived or has not expired by reason
of lapse of time following notification of the Company’s intention to file the Registration
Statement (as defined in Section 9.1(a)) to require the Company to register the sale of any
capital stock owned by such stockholder under the Registration Statement. No further approval or
authority of the Company’s stockholders or the Board of Directors of the Company will be required
for the issuance and sale of the Shares to be sold by the Company as contemplated herein.

          4.6 Due Execution, Delivery and Performance of this Agreement. The Company has full
legal right, corporate power and authority to enter into this Agreement and perform the
transactions contemplated hereby. This Agreement has been duly authorized,

- 10 -

 

executed and delivered by the Company. This Agreement constitutes a legal, valid and binding
agreement of the Company, enforceable against the Company in accordance with its terms, except as
enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or
other similar laws and judicial decisions of general application relating to or affecting the
enforcement of creditors’ rights generally and the application of general equitable principles
relating to the availability of remedies, and except as rights to indemnity or contribution may be
limited by federal or state securities law or the public policy underlying such laws. The
execution and performance of this Agreement and, when executed and delivered, the Investor Rights
Agreement by the Company and the consummation of the transactions contemplated herein and therein
will not violate any provision of the Restated Certificate of Incorporation or Restated Bylaws of
the Company or the organizational documents of any Subsidiary. The execution and performance of
this Agreement and, when executed and delivered, the Investor Rights Agreement will not result in
the creation of any Liens upon any material assets of the Company or any Subsidiary pursuant to the
terms or provisions of, or will not conflict with, result in the breach or violation of, or
constitute, either by itself or upon notice or the passage of time or both, a default under any
material agreement, mortgage, deed of trust, lease, franchise, license, indenture, permit or other
instrument to which any of the Company or any Subsidiary is a party or by which any of the Company
or any Subsidiary or their respective properties may be bound or affected, any statute or any
authorization, judgment, decree, order, rule or regulation of any court or any regulatory body,
administrative agency or other governmental agency or body applicable to the Company or any
Subsidiary or any of their respective properties. No consent, approval, authorization or other
order of any court, regulatory body, administrative agency or other governmental agency or body is
required for the execution and delivery of this Agreement and, when executed and delivered, the
Investor Rights Agreement by the Company or the consummation by the Company of the transactions
contemplated by this Agreement and the Investor Rights Agreement, except for compliance with state
and federal securities laws applicable to the offering of the Shares and such as may be required by
the bylaws and rules of the Financial Industry Regulatory Authority, Inc. or The New York Stock
Exchange, Inc.

          4.7 Accountants. Ernst & Young LLP, who has audited the consolidated financial
statements and the related notes and schedules thereto contained in the Company’s Annual Report on
Form 10-K for the year ended December 31, 2008, are registered independent public accountants as
required by the Securities Act and the rules and regulations promulgated thereunder (the “1933
Act Rules and Regulations”) and by the rules of the Public Accounting Oversight Board.

          4.8 No Defaults or Consents. Neither the execution, delivery or performance of this
Agreement or, when it is executed and delivered, the Investor Rights Agreement, by the Company, nor
the consummation of any of the transactions contemplated hereby and thereby (including, without
limitation, the issuance and sale by the Company of the Shares) and thereby will give rise to a
right to terminate or accelerate the due date of any payment due under or conflict with or result
in the breach of any term or provision of, or constitute a default (or an event that with notice or
lapse of time or both would constitute a default) under, or require any consent or waiver under, or
result in the execution or imposition of any Liens upon any properties or assets of the Company or
its Subsidiaries pursuant to the terms of, any material indenture, loan agreement, credit
agreement, mortgage, deed of trust or other agreement or

- 11 -

 

instrument to which the Company or any of its Subsidiaries is a party or by which either the
Company or its Subsidiaries or any of its or their properties or businesses is bound, or violate
any material franchise, license or permit, or violate any judgment, decree, order, statute, rule or
regulation applicable to the Company or any of its Subsidiaries or violate any provision of the
charter or by-laws of the Company or any of its Subsidiaries, except for such consents or waivers
that have already been obtained and are in full force and effect.

          4.9 Contracts. The material contracts to which the Company is a party that have been
filed as exhibits to the SEC Documents (as defined in Section 4.20) have been duly and
validly authorized, executed and delivered by the Company and constitute the legal, valid and
binding agreements of the Company, enforceable by and against it in accordance with their
respective terms, except as such enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium or other similar laws and judicial decisions of general
application relating to enforcement of creditors’ rights generally, and the application of general
equitable principles relating to or affecting the availability of remedies, and except as rights to
indemnity or contribution may be limited by federal or state securities laws or the public policy
underlying such laws.

          4.10 No Actions. There are no governmental suits, investigations or proceedings
pending or, to the Company’s knowledge, threatened against the Company or any Subsidiary before the
United States Securities and Exchange Commission (the “Commission”) or the United States
Department of Justice. Except as disclosed in the SEC Documents, there are no other legal or
governmental actions, suits, investigations or proceedings pending or, to the Company’s knowledge,
threatened against the Company or any Subsidiary before or by any arbitrator, court, regulatory
body or administrative agency or any other governmental agency or body, domestic or foreign (each,
an “Action”), which Actions, would reasonably be expected to have a Material Adverse
Effect. There has not been in the three (3) year period prior to the date hereof, and to the
knowledge of the Company, there is not pending or contemplated, any investigation by the Commission
involving the Company or any current or former director or executive officer of the Company with
regard to the Company. Upon the reasonable request of the Purchaser, the Company shall provide to
the Purchaser a written summary of the status of the Actions disclosed in the SEC Documents. The
Company has not received, nor is the Company aware of, any stop order or other order from the
Commission suspending the effectiveness of any registration statement filed by the Company or any
Subsidiary under the Exchange Act or the Securities Act. No labor disturbance by the employees of
the Company exists or, to the Company’s knowledge, is imminent, that would have or reasonably be
expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary is a party to
or subject to the provisions of any injunction, judgment, decree or order of any court, regulatory
body, administrative agency or other governmental agency or body. None of the currently pending
or, to the Company’s knowledge, currently threatened, Actions against the Company will, if
determined against the Company by a court or other body of competent jurisdiction, reasonably be
expected to have a Material Adverse Effect. For the purposes of this Agreement, the term
“Material Adverse Effect” shall mean any event, occurrence, fact, condition, change,
development or effect that has or would reasonably be expected to have, individually or in the
aggregate, a material adverse effect on the business, properties, assets, liability, operations,
results of operations, condition (financial or otherwise) or prospects of the Company and its
Subsidiaries, taken as a whole, or on the transactions contemplated hereby or by the agreements

- 12 -

 

and instruments to be entered into in connection herewith or therewith, or on the authority or
ability of the Company to perform its obligations hereunder and/or under any of the agreements to
which it is bound in connection with the Pingpong Transactions; provided, however, that in
determining whether a Material Adverse Effect has occurred with respect to the Company and its
Subsidiaries, there shall be excluded any effect on the Company and its Subsidiaries relating to or
arising in connection with: (a) any action required to be taken or, the failure to take any action
prohibited from being taken, pursuant to the terms and conditions of this Agreement; (b) changes
affecting the economies of Canada, the United States, the PRC or any foreign market where the
Company or its Subsidiaries have material operations or sales generally (provided in each case that
such changes do not have a unique or disproportionate impact on the Company, such Subsidiaries or
their respective businesses); (c) changes in, or events or conditions affecting, the seismic,
petroleum drilling or services industries generally, including, without limitation, changes
resulting from the price of oil, gas, natural gas liquids or other hydrocarbon products (provided
in each case that such changes do not have a unique or disproportionate impact on the Company and
its Subsidiaries); (d) any natural disaster or hostilities, acts of war or terrorism or any
material escalation of any such hostilities, acts of war or terrorism existing as of the date
hereof; or (e) any action to which the Purchaser has expressly consented in writing after the
Company has explicitly informed and consulted with the Purchaser.

          4.11 Properties. The Company and each Subsidiary has good and valid title to all
items of tangible personal property described as owned by it in the consolidated financial
statements included in the SEC Documents, in each case free and clear of all Liens except for those
disclosed in the SEC Documents, or those, individually or in the aggregate, that (i) do not
materially interfere with the use made and proposed to be made of such property by the Company and
its Subsidiaries or (ii) would neither have nor reasonably be expected to have a Material Adverse
Effect. Any real property described in the SEC Documents as being leased by the Company or any
Subsidiary that is material to the business of the Company and its Subsidiaries, taken as a whole,
is held by them under valid, existing and enforceable leases, except those that, individually or in
the aggregate, (A) do not materially interfere with the use made or proposed to be made of such
property by the Company and its Subsidiaries or (B) would neither have nor reasonably be expected
to have a Material Adverse Effect.

          4.12 No Material Adverse Change. Except as disclosed in the SEC Documents, since
December 31, 2008, (i) the Company and its Subsidiaries have not incurred any material liabilities
or obligations, indirect or contingent, or entered into any material agreement or other transaction
that is not in the ordinary course of business or that is not required to be reflected in the
Company’s consolidated financial statements pursuant to applicable accounting principles or that
could reasonably be expected to result in a material reduction in the future earnings of the
Company; (ii) the Company and its Subsidiaries have not sustained any material loss or material
interference with their businesses or properties from fire, flood, windstorm, accident, acts of
terrorism or other calamity not covered by insurance; (iii) the Company and its Subsidiaries have
not paid or declared any dividends or other distributions with respect to their capital stock and
neither of the Company nor any Subsidiary is in material default in the payment of principal or
interest on any outstanding long-term debt obligations; (iv) there has not been any material change
in the capital stock of the Company or its Subsidiaries other than the sale of the Shares hereunder
and shares or options issued (and repurchased) pursuant to employee equity incentive plans or
purchase plans approved by the Company’s Board of Directors, or indebtedness

- 13 -

 

material to the Company or its Subsidiaries (other than in the ordinary course of business and
any required scheduled payments); (v) the Company has not changed any accounting methods, had
significant disputes with its accountant on any accounting treatment related matters or changed its
accountant in the past twelve-month period, and (vi) there has not occurred any event that has
caused or would reasonably be expected to cause a Material Adverse Effect.

          4.13 Intellectual Property. Except as disclosed in the SEC Documents, (i) the Company
and each Subsidiary owns or has obtained valid and enforceable licenses or options for the
inventions, patent applications, patents, trademarks (both registered and unregistered), trade
names, copyrights and trade secrets necessary for the conduct of its respective business as
currently conducted (collectively, the “Intellectual Property”); and (ii) (a) there are no
third parties who have any ownership rights or other claims to any Intellectual Property that is
owned by, or has been licensed to, the Company or any Subsidiary for the products and services of
the Company and its Subsidiaries described in the SEC Documents that would preclude the Company or
any Subsidiary from conducting its business as currently conducted and have or reasonably be
expected to have a Material Adverse Effect, except for the ownership rights of the owners of the
Intellectual Property licensed or optioned by the Company or any Subsidiary; (b) there are
currently no sales of any products or the provision of services that would constitute an
infringement by third parties of any Intellectual Property owned, licensed or optioned by the
Company or any Subsidiary, which infringement would have or reasonably be expected to have a
Material Adverse Effect; (c) there is no pending or, to the Company’s knowledge, threatened Action
or claim by others challenging the rights of the Company or any Subsidiary in or to any
Intellectual Property owned, licensed or optioned by the Company or any Subsidiary, other than
claims that would neither have nor reasonably be expected to have a Material Adverse Effect; (d)
there is no pending or, to the Company’s knowledge, threatened Action or claim by others
challenging the validity or scope of any Intellectual Property owned, licensed or optioned by the
Company or any Subsidiary, other than Actions or claims that would neither have nor reasonably be
expected to have a Material Adverse Effect; and (e) except as set forth in Schedule 4.13, there is
no pending or, to the Company’s knowledge, threatened Action or claim by others that the Company or
any Subsidiaries infringes or otherwise violates any patent, trademark, copyright, trade secret or
other proprietary right of others, other than Actions and claims that would neither have nor
reasonably be expected to have a Material Adverse Effect.

          4.14 Compliance. Neither the Company nor any of its Subsidiaries have been advised,
nor do any of them have any reason to believe, that it is not conducting business in compliance
with all applicable laws, rules and regulations of the jurisdictions in which it is conducting
business, including, without limitation, all applicable local, state and federal environmental laws
and regulations, except where failure to be so in compliance would neither have nor reasonably be
expected to have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is in
default under or in violation of (and no event has occurred that has not been waived that, with
notice or lapse of time or both, would result in a default by the Company or any Subsidiary under),
nor has the Company or any Subsidiary received notice, except as set forth in Schedule 4.14, of a
claim that it is in default under or that it is in violation of, any indenture, loan or credit
agreement or any other agreement or instrument to which it is a party or by with it or any of its
properties is bound (whether or not such default or violation has been waived), other than such
defaults, claims or violations that individually or in the aggregate would neither have nor
reasonably be expected to have a Material Adverse Effect.

- 14 -

 

          4.15 Taxes. The Company and each Subsidiary has filed all required tax returns, and
all such tax returns are true, correct and complete in all material respects. The Company and each
Subsidiary has fully paid all taxes shown as due thereon, except for any claims for refund with
respect thereto. Neither the Company nor any Subsidiary has knowledge of any deficiency or
assessment with respect to liabilities for any material taxes that has been or might be asserted or
threatened against it, which has not been fully paid or finally settled, unless being contested in
good faith through appropriate proceedings and for which adequate reserves are reflected in the
Company’s consolidated financial statements. All tax liabilities accrued through the date hereof
have been, and all tax liabilities accrued through the Closing Date will be, adequately reserved
for in the Company’s consolidated financial statements.

          4.16 Transfer Taxes. On the Closing Date, all stock transfer or other taxes (other
than income taxes) that are required to be paid in connection with the transactions contemplated by
this Agreement will be, or will have been, fully paid by the Company and all laws imposing such
taxes will be or will have been fully complied with.

          4.17 Investment Company. The Company is not an “investment company” or “promoter” or
“principal underwriter” for an investment company, within the meaning of the Investment Company Act
of 1940, as amended, and the rules and regulations of the Commission promulgated thereunder.

          4.18 Securities Law Exemption. The Company has not taken, nor will it hereafter take,
any action to sell, offer for sale or solicit offers to buy any securities of the Company that
could result in the sale of the Shares pursuant to this Agreement not being exempt from the
registration requirements of Section 5 of the Securities Act.

          4.19 Insurance. The Company maintains insurance underwritten by insurers of
recognized financial responsibility, of the types and in the amounts that the Company reasonably
believes is adequate for its business operations, including, but not limited to, (a) insurance
covering all real and personal property owned or leased by the Company against theft, damage,
destruction, acts of vandalism and all other risks customarily insured against, and (b) directors’
and officers’ liability insurance covering the officers and directors of the Company, with such
deductibles as are customary for companies in the same or similar business, all of which insurance
is in full force and effect.

          4.20 Additional Information. The information contained in the following documents
(the “SEC Documents”), which the Company has furnished to the Purchaser (or will furnish
prior to the Closing) or which are otherwise available through the Commission’s EDGAR system, as of
the dates thereof, did not contain an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein, in light
of the circumstances in which they were made, not misleading:

     (a) the Company’s Annual Reports on Form 10-K for the fiscal years ended
December 31, 2008 and December 31, 2009;

     (b) the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended
March 31, 2009;

- 15 -

 

     (c) the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended
June 30, 2009, as amended by Form 10-Q/A filed with the Commission on November 9,
2009;

     (d) the Company’s Quarterly Report on Form 10-Q for the fiscal quarter ended
September 30, 2009;

     (e) the Company’s Definitive Proxy Statement for the Annual Meeting of
Stockholders held on May 27, 2009;

     (f) the Company’s Schedule TO filed on April 9, April 24 and December 23, 2009;

     (g) the Company’s Current Reports on Form 8-K filed or furnished on January 5,
2009, January 5, 2009, January 9, 2009, January 29, 2009, February 27, 2009, March
4, 2009, March 24, 2009, April 1, 2009, May 6, 2009, May 29, 2009, June 2, 2009,
June 5, 2009, June 15, 2009, June 22, 2009, July 1, 2009, August 6, 2009, October 6,
2009, October 8, 2009, October 15, 2009, October 27, 2009 (as amended by the
Company’s Current Report on Form 8-K/A filed on October 29, 2009), November 4, 2009,
December 3, 2009, January 14, 2010, February 1, 2010 and February 17, 2010;

     (h) the description of the Company’s common stock contained in its Registration
Statement on Form 8-A filed on October 17, 1994, as amended by the Company’s Current
Reports on Form 8-K filed with the Commission on March 8, 2002, December 20, 2007
and February 28, 2008, respectively; and

     (i) all other documents, if any, filed by the Company (excluding Current
Reports on Form 8-K (or the portions thereof) furnished under Item 2.02 or Item 7.01
of Form 8-K) with the Commission since December 31, 2008 pursuant to the reporting
requirements of the Exchange Act.

     Except with respect to the filing set forth in Section 4.20(c) (that has been amended
as described therein), the SEC Documents at the time they became effective or were filed with or
furnished to the Commission, as the case may be, complied in all material respects with the
requirements of the Exchange Act, as applicable, and the rules and regulations of the Commission
thereunder (the “1934 Act Rules and Regulations” and, together with the 1933 Act Rules and
Regulations, the “Rules and Regulations”). In the past 24 calendar months, the Company has
filed or furnished all documents required to be filed or furnished by it prior to the date hereof
with the Commission pursuant to the reporting requirements of the Exchange Act and the 1934 Act
Rules and Regulations.

          4.21 Price of Common Stock. The Company has not taken, and will not take, directly or
indirectly, any action designed to cause or result in, or that has constituted or that might
reasonably be expected to constitute, the stabilization or manipulation of the price of the shares
of the Common Stock to facilitate the sale or resale of the Shares.

- 16 -

 

          4.22 Use of Proceeds. The Company shall use the proceeds from the sale of the Shares
only for working capital and the repayment of existing indebtedness.

          4.23 References to the Purchaser. Except as otherwise required by applicable law or
regulation, the Company shall not use the Purchaser’s name or the name of any of its Affiliates (as
defined below) in any advertisement, announcement, press release or other similar public
communication unless it has received the prior written consent of the Purchaser for the specific
use contemplated, which consent shall not be unreasonably withheld or delayed. For purposes of
this Agreement, “Affiliate” means, with respect to any natural person, firm, partnership,
association, corporation, limited liability company, company, trust, entity, public body or
government (a “Person”), any Person that, directly or indirectly, controls, is controlled
by, or is under common control with, such Person. The term “control” (including the terms
“controlled by” and “under common control with”) as used in this definition means the possession,
directly or indirectly, of the power to direct or cause the direction of management and policies of
a Person, whether through the ownership of voting securities, by contract or otherwise.

          4.24 Related-Party Transactions. No transaction has occurred between or among the
Company, on the one hand, and its Affiliates, officers or directors on the other hand, that is
required to have been described under applicable securities laws and the rules and regulations
promulgated thereunder in its Exchange Act filings, and is not so described in such filings.

          4.25 Off-Balance Sheet Arrangements. There is no transaction, arrangement or other
relationship between the Company and an unconsolidated or other off-balance sheet entity that is
required to be disclosed by the Company in its Exchange Act filings and is not so disclosed or that
otherwise would have or would reasonably be expected to have a Material Adverse Effect. There are
no such transactions, arrangements or other relationships with the Company that may create any
material contingencies or liabilities that are not otherwise disclosed by the Company in the SEC
Documents.

          4.26 Governmental Permits, Etc. The Company and each Subsidiary has all franchises,
licenses, certificates and other authorizations from federal, state or local governments or
governmental agencies, departments or bodies that are currently necessary for the operation of the
business of the Company and its Subsidiaries as currently conducted, except where the failure to
possess currently such franchises, licenses, certificates and other authorizations would neither
have nor reasonably be expected to have a Material Adverse Effect. Neither the Company nor any
Subsidiary has received any notice of proceedings relating to the revocation or modification of any
such permit that, if the subject of an unfavorable decision, ruling or finding, would have or would
reasonably be expected to have a Material Adverse Effect.

          4.27 Financial Statements. The consolidated financial statements of the Company and
the related notes and schedules thereto included in its Exchange Act filings, as they may have been
amended prior to the date hereof (and as they may be amended prior to the Closing Date), present
fairly, in all material respects, the financial condition of the Company and its consolidated
Subsidiaries as of the dates thereof and the results of operations and cash

- 17 -

 

flows of the Company and its consolidated Subsidiaries at the dates and for the periods
covered thereby. Such financial statements and the related notes and schedules thereto have been
prepared in accordance with U.S. GAAP consistently applied throughout the periods involved (except
as otherwise noted therein) and all adjustments necessary for a fair presentation of results for
such periods have been made; provided, however, that the unaudited financial statements are subject
to normal year-end audit adjustments (which are not expected to be material) and do not contain all
footnotes required under generally accepted accounting principles.

          4.28 Registration and Listing Compliance. The Company is in compliance with the
requirements of The New York Stock Exchange for continued listing of the Common Stock thereon. The
Company has taken no action designed to, or likely to have the effect of, terminating the
registration of the Common Stock under the Exchange Act or the listing of the Common Stock on The
New York Stock Exchange, nor has the Company received any notification that the Commission or The
New York Stock Exchange is currently contemplating terminating such registration or listing. The
transactions contemplated by this Agreement will not contravene the rules and regulations of The
New York Stock Exchange. The Company will comply with all applicable requirements of The New York
Stock Exchange with respect to the issuance of the Shares and shall cause the Shares to be listed
on The New York Stock Exchange and listed on any other exchange on which the Common Stock is listed
on or before (subject to official notice of issuance) the Closing Date.

          4.29 Internal Accounting Controls. The Company maintains a system of internal
accounting controls sufficient to provide reasonable assurances that (i) transactions are executed
in accordance with management’s general or specific authorization; (ii) transactions are recorded
as necessary to permit preparation of financial statements in conformity with U.S. GAAP and to
maintain accountability for assets; (iii) access to assets is permitted only in accordance with
management’s general or specific authorization; and (iv) the recorded accountability for assets is
compared with existing assets at reasonable intervals and appropriate action is taken with respect
to any differences. The Company maintains disclosure controls and procedures (as defined in Rules
13a-15 and 15d-15 under the Exchange Act) that are designed to ensure that material information
relating to the Company is made known to the Company’s principal executive officer and the
Company’s principal financial officer or Persons performing similar functions. Except as set forth
in the SEC Documents, there is and has been no failure on the part of the Company, or to its
knowledge after due inquiry, any of the Company’s directors or officers, in their capacities as
such, to comply with any applicable provisions of the Sarbanes Oxley Act of 2002 and the rules and
regulations promulgated therewith (the “Sarbanes Oxley Act”). Each of the principal
executive officer and the principal financial officer of the Company (or each former principal
executive officer of the Company and each former principal financial officer of the Company as
applicable) has made all certifications required by Sections 302 and 906 of the Sarbanes-Oxley Act
with respect to all reports, schedules, forms, statements and other documents required to be filed
by it with the Commission. For purposes of the preceding sentence, “principal executive officer”
and “principal financial officer” shall have the meanings given to such terms in the Sarbanes-Oxley
Act. The Company has taken all reasonable actions necessary to ensure that it is in compliance
with all provisions of the Sarbanes-Oxley Act that are in effect and with which the Company is
required to comply.

- 18 -

 

          4.30 Foreign Corrupt Practices Act. Neither the Company nor any Subsidiary has, nor,
to the knowledge of the Company, has any director, officer, agent or employee, in the course of its
actions for, or on behalf of, the Company (i) used any corporate funds for any unlawful
contribution, gift, entertainment or other unlawful expenses relating to political activity; (ii)
made any direct or indirect unlawful payment to any foreign or domestic government official or
employee from corporate funds; (iii) violated or is in violation of any provision of the U.S.
Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff,
influence payment, kickback or other unlawful payment to any foreign or domestic government
official or employee.

          4.31 Employee Relations. Neither the Company nor any Subsidiary is a party to any
collective bargaining agreement or employs any member of a union (other than with regards to
statutory unions required under foreign laws and regulations). The Company and each Subsidiary
believe that their relations with their employees are amicable. No executive officer of the
Company (as defined in Rule 501(f) promulgated under the Securities Act) has notified the Company
that such officer intends to leave the Company or otherwise terminate such officer’s employment
with the Company. No executive officer of the Company is, or is now expected to be, in violation
of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement, non-competition agreement or any other agreement or any restrictive
covenant, and the continued employment of each such executive officer does not subject the Company
or any Subsidiary to any liability with respect to any of the foregoing matters.

          4.32 ERISA. Each material employee benefit plan, within the meaning of Section 3(3)
of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), that is
maintained, administered or contributed to by the Company or any of its Affiliates for employees or
former employees of the Company and its Subsidiaries, or to which the Company or any of its
Subsidiaries has any liability thereunder (a “Company Benefit Plan”), has been maintained
in material compliance with its terms and the requirements of any applicable statutes, orders,
rules and regulations, including but not limited to ERISA and the Internal Revenue Code of 1986, as
amended (the “Code”); no action, dispute, claim, suit or proceeding is pending or, to the
knowledge of the Company, threatened with respect to any Company Benefit Plan (other than claims
for benefits in the ordinary course) that could result in a material liability to the Company; no
prohibited transaction, within the meaning of Section 406 of ERISA or Section 4975 of the Code, has
occurred that could result in a material liability to the Company with respect to any such plan
excluding transactions effected pursuant to a statutory or administrative exemption; and for each
such plan that is subject to the funding rules of Section 412 of the Code or Section 302 of ERISA,
no “accumulated funding deficiency”, as defined in Section 412 of the Code, has been incurred,
whether or not waived, and the fair market value of the assets of each such plan (excluding for
these purposes accrued but unpaid contributions) exceeds the present value of all benefits accrued
under such plan determined using reasonable actuarial assumptions.

          4.33 Environmental Matters. There has been no storage, disposal, generation,
manufacture, transportation, handling or treatment of toxic wastes, hazardous wastes or hazardous
substances by the Company or to its knowledge, any Subsidiary (or, to the knowledge of the Company,
any of their predecessors in interest) at, upon or from any of the

- 19 -

 

property now or previously owned or leased by the Company or any Subsidiary in material
violation of any applicable law, ordinance, rule, regulation, order, judgment, decree or permit or
that would require remedial action under any applicable law, ordinance, rule, regulation, order,
judgment, decree or permit; there has been no material spill, discharge, leak, emission, injection,
escape, dumping or release of any kind into such property or into the environment surrounding such
property of any toxic wastes, medical wastes, solid wastes, hazardous wastes or hazardous
substances due to or caused by the Company or any Subsidiary or with respect to which the Company
or any Subsidiary has knowledge; the terms “hazardous wastes,” “toxic wastes,” “hazardous
substances” and “medical wastes” shall have the meanings specified in any applicable local, state,
federal and foreign laws or regulations with respect to environmental protection.

          4.34 Integration; Other Issuances of Shares. The Company has not issued any shares of
Common Stock or shares of any series of preferred stock or other securities or instruments
convertible into, exchangeable for or otherwise entitling the holder thereof to acquire shares of
Common Stock that would be integrated with the sale of the Shares to the Purchaser for purposes of
the Securities Act or of any applicable stockholder approval provisions, including, without
limitation, under the rules and regulations of any securities exchange or automated quotation
system on which any of the securities of the Company are listed or designated. Assuming the
accuracy of the representations, warranties and covenants of the Purchaser to the Company as set
forth herein, the offer and sale of the Shares by the Company to the Purchaser pursuant to this
Agreement will be exempt from the registration requirements of the Securities Act.

          4.35 Disclosure. All disclosure provided to the Purchaser regarding the Company, its
business, the transactions contemplated hereby, furnished by or on behalf of the Company, were, as
of the date made, true and correct in all material respects and did not contain any untrue
statement of material fact or omit to state any material fact necessary in order to make the
statements made therein, in the light of the circumstances under which they were made, not
misleading.

          4.36 Authorization of the Investor Rights Agreement. As of the Closing Date, the
Investor Rights Agreement will have been duly authorized by the Company, and will be validly
executed and delivered by the Company and assuming due authorization, execution and delivery of
such agreement by each other party thereto, will constitute a valid and binding obligation of the
Company, enforceable against the Company in accordance with its terms, except to the extent that
the enforcement thereof may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium or similar laws affecting the enforcement of creditors’ rights generally and general
equitable principles, regardless of whether such enforceability is considered in a proceeding at
law or in equity.

          4.37 Organization Documents. The Company has provided the Purchaser with true,
accurate and complete copies of the Company’s Restated Certificate of Incorporation and the Amended
and Restated Bylaws and any material amendments thereto.

     5. Representations, Warranties and Covenants of the Purchaser. The Purchaser
represents and warrants to, and covenants with, the Company that:

- 20 -

 

          5.1 Experience. (i) The Purchaser is knowledgeable, sophisticated and experienced in
financial and business matters, in making, and is qualified to make, decisions with respect to
investments in securities representing an investment decision like that involved in the purchase of
the Shares, including, without limitation, investments in securities issued by the Company and
comparable entities, and the Purchaser has undertaken an independent analysis of the merits and the
risks of an investment in the Shares, based on the Purchaser’s own financial circumstances; (ii)
the Purchaser has had the opportunity to request, receive, review and consider all information it
deems relevant in making an informed decision to purchase the Shares and to ask questions of, and
receive answers from, the Company concerning such information; (iii) the Purchaser is acquiring the
Shares hereunder for its own account and with no present intention of distributing any of such
Shares or any arrangement or understanding with any other Persons regarding the distribution of
such Shares (provided that this clause (iii) shall not limit the Purchaser’s right to resell the
Shares pursuant to the Registration Statement or in compliance with the Securities Act and the
Rules and Regulations, or, other than with respect to any claims arising out of a breach of this
clause (iii), the Purchaser’s right to indemnification under the Investor Rights Agreement); (iv)
subject to Section 6, the Purchaser will not, directly or indirectly, Transfer (as defined
in Section 6) (or solicit any offers to Transfer any of the Shares, nor will the Purchaser
engage in any short sale that results in a Transfer of any of the Shares by the Purchaser, except
in compliance with the Securities Act and the Rules and Regulations and any applicable state
securities laws; (v) the Purchaser will comply with the prospectus delivery requirements of the
Securities Act as applicable to it in connection with resales of the Shares pursuant to the
Registration Statement or with the applicable requirements of any exemption from the Securities
Act; (vi) the Purchaser has had an opportunity to discuss this investment with representatives of
the Company and ask questions of them but has not relied on any communication or recommendation
from any representative of the Company and (vii) the Purchaser is an “accredited investor” within
the meaning of Rule 501 under the Securities Act.

          5.2 Reliance on Exemptions.

     (a) The Purchaser understands that the Shares are being offered and sold to it
in reliance upon specific exemptions from the registration requirements of the
Securities Act, the Rules and Regulations and state securities laws and that the
Company is relying upon the truth and accuracy of, and the Purchaser’s compliance
with, the representations, warranties, agreements, acknowledgments and
understandings of the Purchaser set forth herein in order to determine the
availability of such exemptions and the eligibility of the Purchaser to acquire the
Shares.

     (b) The Purchaser acknowledges that no action has been or will be taken in any
jurisdiction outside the U.S. by the Company that would permit an offering of the
Shares, or possession or distribution of offering materials in connection with such
offering, in any jurisdiction outside the U.S. where action for that purpose is
required. The Purchaser will comply with all applicable laws and regulations in each
foreign jurisdiction in which it purchases, offers, sells or delivers Shares or has
in its possession or distributes any offering material, in all cases at its own
expense.

- 21 -

 

          5.3 Investment Decision. The Purchaser understands that nothing in this Agreement or
any other materials presented to the Purchaser in connection with the purchase and sale of the
Shares constitutes legal, tax or investment advice. The Purchaser has consulted such legal, tax
and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in
connection with its purchase of the Shares.

          5.4 Risk of Loss. Without prejudice to its legal right to claims (if any) against the
Company in the event of a breach by the Company of any of its representation and warranties,
covenants or other terms hereunder on which the Purchaser has relied to make its investment in the
Shares, the Purchaser understands that its investment in the Shares involves a significant degree
of risk, including a risk of total loss of the Purchaser’s investment, and the Purchaser has full
cognizance of and understands all of the risk factors related to the Purchaser’s purchase of the
Shares. The Purchaser understands that the market price of the Common Stock has been volatile and
that no representation is being made as to the future value of the Common Stock.

          5.5 Legend; Legend Removal.

     (a) The Purchaser understands that, until such time as the Shares are sold
pursuant to the Registration Statement, or the Shares are sold pursuant to Rule 144
promulgated by the Commission under the Securities Act (“Rule 144”) without
any restriction as to the number of securities as of a particular date that can then
be immediately sold, the certificates evidencing the Shares will be subject to a
stop transfer order with the Company’s transfer agent and will bear a restrictive
legend in substantially the following form:

“THE SHARES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), OR THE SECURITIES LAWS OF ANY STATE OR OTHER
JURISDICTION. THE SHARES MAY NOT BE OFFERED, SOLD, PLEDGED OR
OTHERWISE TRANSFERRED EXCEPT (1) PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT OR (2) PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT, IN EACH
CASE IN ACCORDANCE WITH ALL APPLICABLE STATE SECURITIES LAWS AND THE
SECURITIES LAWS OF OTHER JURISDICTIONS, AND IN THE CASE OF A
TRANSACTION EXEMPT FROM REGISTRATION, UNLESS THE COMPANY HAS
RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT THAT
SUCH TRANSACTION DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES
ACT AND SUCH OTHER APPLICABLE LAWS OR THE COMPANY HAS RECEIVED FROM
THE HOLDER REASONABLE ASSURANCE THAT THE SHARES CAN BE SOLD,

- 22 -

 

ASSIGNED OR TRANSFERRED PURSUANT TO RULE 144 UNDER THE SECURITIES
ACT.

     (b) The legend set forth above shall be removed and the Company shall issue a
certificate without such legend to the holder of the Shares upon which it is stamped
or issue such Shares to such holder by electronic delivery at the applicable balance
account at The Depository Trust Company (“DTC”), if, unless otherwise
required by state securities laws, (i) in connection with any Transfer of the Shares
that is to be effected pursuant to a Registration Statement to cover registered
resales of such Shares, such Registration Statement has been declared effective
under the Securities Act and remains effective under such Act, or (ii) in connection
with any Transfer of Shares that is not to be effected pursuant to such Registration
Statement, such holder first provides the Company with an opinion of counsel
reasonably satisfactory to the Company, in a generally acceptable form, to the
effect that such Transfer of the Shares may be made without registration under the
applicable requirements of the Securities Act and that such legend is no longer
required, or (iii) such holder first provides the Company with reasonable assurance
that the Shares can be Transferred pursuant to Rule 144. The Company shall be
responsible for the fees of its transfer agent and all DTC fees associated with such
issuance.

     (c) In addition, for so long as the holder of the Shares is subject to the
transfer restrictions contained in Section 13 of the Investor Rights Agreement, the
Company may require that the Shares bear a legend or other restriction substantially
to the following effect: “THIS SECURITY IS SUBJECT TO RESTRICTIONS ON TRANSFER SET
FORTH IN SECTIONS 13 AND 14 OF THE INVESTOR RIGHTS AGREEMENT BY AND AMONG THE
COMPANY AND CERTAIN OTHER PARTIES THERETO.” Such legend shall be removed at the
request of any holder thereof that is not subject to the transfer restrictions
contained in the Investor Rights Agreement.

          5.6 Organization; Validity; Enforcements. The Purchaser further represents and
warrants to, and covenants with, the Company that (i) the Purchaser has full right, power,
authority and capacity to enter into this Agreement and to consummate the transactions contemplated
hereby and has taken all necessary action to authorize the execution, delivery and performance of
this Agreement, (ii) the making and performance of this Agreement by the Purchaser and the
consummation of the transactions herein contemplated will not violate any provision of the
organizational documents of the Purchaser or conflict with, result in the breach or violation of,
or constitute, either by itself or upon notice or the passage of time or both, a default under any
material agreement, mortgage, deed of trust, lease, franchise, license, indenture, permit or other
instrument to which the Purchaser is a party or, any statute or any authorization, judgment,
decree, order, rule or regulation of any court or any regulatory body, administrative agency or
other governmental agency or body applicable to the Purchaser, (iii) no consent, approval,
authorization or other order of any court, regulatory body, administrative agency or other
governmental agency or body is required on the part of the Purchaser for the execution and delivery
of this Agreement or the consummation of the transactions contemplated by this Agreement, (iv) upon
the execution and delivery of this Agreement, this Agreement

- 23 -

 

shall constitute a legal, valid and binding obligation of the Purchaser, enforceable in
accordance with its terms, except as such enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, moratorium or other similar laws or judicial decisions of general
application relating to or affecting the enforcement of creditors’ rights generally and the
application of equitable principles relating to the availability of remedies, and except as rights
to indemnity or contribution may be limited by federal or state securities laws or the public
policy underlying such laws and (v) there is not in effect any order enjoining or restraining the
Purchaser from entering into or engaging in any of the transactions contemplated by this Agreement.

          5.7 Authorization of the Investor Rights Agreement. As of the Closing Date, the
Investor Rights Agreement will have been duly authorized by the Purchaser and will be validly
executed and delivered by the Purchaser and assuming due authorization, execution and delivery of
such agreement by each other party thereto, will constitute a valid and binding obligation of the
Purchaser, enforceable against the Purchaser in accordance with its terms, except to the extent
that the enforcement thereof may be limited by applicable bankruptcy, insolvency, reorganization,
moratorium or similar laws affecting the enforcement of creditors’ rights generally and general
equitable principles, regardless of whether such enforceability is considered in a proceeding at
law or in equity.

          5.8 Ownership of Common Stock; Filings by the Purchaser.

     (a) As of the date hereof, neither the Purchaser nor any of its Affiliates is
the Beneficial Owner of any shares of Common Stock, except for any shares of Common
Stock described in Section 5.8(b) below. For purposes of this Section
5.8, “Beneficial Owner” has the meaning assigned to such term in Rule
13d-3 and Rule 13d-5 under the Exchange Act, except that, in calculating the
beneficial ownership of any particular “person” (as that term is used in Section
13(d)(3) of the Exchange Act), such “person” will be deemed to have beneficial
ownership of all securities that such “person” has the right to acquire by
conversion or exercise of other securities, whether such right is currently
exercisable or is exercisable only after the passage of time.

     (b) Prior to the Closing, the Purchaser shall not acquire any shares of Common
Stock except pursuant to (i) any exercise of the Warrant, (ii) any conversion of the
Convertible Notes or (iii) this Agreement, and then only in accordance with the
express terms of such document or instrument and in compliance with any and all
Required Approvals, applicable rules and regulations of The New York Stock Exchange
and other required third party consents and approvals.

     (c) The Purchaser shall make such filings with the Commission as may be
required or as the Purchaser may deem necessary or advisable in connection with the
transactions contemplated in this Agreement, including any filing under Sections
13(d) and 16(a), as may be applicable, of the Exchange Act and the 1934 Act Rules
and Regulations.

- 24 -

 

     6. Transfers; DTC.

          6.1 Transfers. Subject to Section 5.5 and Section 9.2, the Purchaser
shall be able to directly or indirectly transfer, sell, contract to sell, assign, pledge, convey,
lend, hypothecate, grant any option to purchase, purchase any option to sell, make any short sale
or otherwise encumber or dispose of (including entering into any swap or other arrangement that
transfers to another, in whole or in part, any of the economic consequence of ownership interests)
(each such transaction, a “Transfer”) all or any portion of the Shares in compliance with
the Investor Rights Agreement. Notwithstanding the foregoing, the Purchaser shall not knowingly
Transfer all or any portion of the Shares to the Company’s competitors identified to the Purchaser
in that certain notice letter delivered to Purchaser contemporaneously with the execution and
delivery hereof; provided that the foregoing shall not restrict the Purchaser from selling
any Shares on any stock exchange or other electronic communication network used in the buying or
selling of securities, including the New York Stock Exchange, where the identity of the purchasers
on such exchange cannot be determined or controlled by the Purchaser (unless the Purchaser knows or
has reason to know that the purchasers of the Shares are among those identified in such notice
letter).

          6.2 DTC. The Company shall, at its expense, make the Shares issued and sold in
accordance with this Agreement eligible for clearance and settlement through the facilities of the
DTC.

     7. Regulatory Matters.

          7.1 Further Assurances Regarding Regulatory Matters. Subject to Section 7.7,
the Purchaser and the Company shall each cooperate with the other Party, and shall use its
reasonable best efforts to take, or cause to be taken, all actions, and to do, or cause to be done,
and to assist such other Party in doing, all things necessary, proper or advisable to consummate
and make effective, in the most expeditious manner practicable, the execution, delivery and
performance of this Agreement and the consummation of the transactions contemplated hereby,
including (i) the obtaining of all necessary actions or non-actions, waivers, consents and
approvals from Governmental Entities and the making of any and all necessary registrations and
filings (including filings with Governmental Entities) and the taking of all reasonable steps as
may be necessary to obtain an approval or waiver from, or to avoid an action or proceeding by, any
Governmental Entity, (ii) the obtaining of all necessary consents, approvals or waivers from third
parties (including any unions, works councils or other labor organizations), (iii) the defending of
any lawsuits or other legal proceedings, whether judicial or administrative, challenging the
Transaction Term Sheet, this Agreement or any agreement, document or instrument in connection
therewith, or the consummation of the transactions contemplated hereby or thereby, including
seeking to have any stay or temporary restraining order entered by any court or other Governmental
Entity vacated or reversed and (iv) the execution and delivery of any additional agreements,
documents or instruments necessary to consummate the transactions contemplated by this Agreement
and to fully carry out the purposes hereof.

          7.2 Consultation. Subject to Section 7.7, the Purchaser and the Company shall
each have the right to review in advance, and, to the extent practicable, each will consult the
other on, in each case subject to applicable laws relating to the confidentiality of information,
the

- 25 -

 

information that appears in any filing made with, or written materials submitted to, any third
party or any Governmental Entity in connection with the transactions contemplated by this
Agreement. In exercising the foregoing right, each of the Parties shall act reasonably and as
promptly as practicable. The Parties shall consult with each other with respect to the obtaining of
all permits, consents, approvals and authorizations of all third Parties and Governmental Entities
necessary or advisable to consummate the transactions contemplated by this Agreement and each Party
will keep the other apprised of the status of matters relating to completion of the transactions
contemplated by this Agreement.

          7.3 Furnishing of Information. Subject to Section 7.7, each of the Parties
shall, upon request, furnish to the other all information concerning itself, its Subsidiaries,
directors, officers and shareholders, and such other matters as may be reasonably necessary or
advisable in connection with any statement, filing, notice or application made by or on behalf of
any of them or any of their respective Subsidiaries, to any Governmental Entity in connection with
the transactions contemplated by this Agreement.

          7.4 Communications. Subject to Section 7.7, each of the Parties shall (i)
promptly inform and provide the other Party with a copy of any material communication received by
such Party from any Governmental Entity in connection with the transactions contemplated by this
Agreement and (ii) permit the other Party reasonable time and notice (subject to the limitation
that, with respect to responses to inquiries from CFIUS during the Exon-Florio review process, such
Party may not preclude the other Party from responding within the timeframe required under the
CFIUS regulations, 31 C.F.R. Sec. 800.403(a)(3)) to (x) review and comment in advance on any
material communication to be made or delivered to CFIUS, including any proposed understanding,
undertakings or agreements, (y) consult with the other Party in advance of any meeting or
conference with CFIUS and (z) attend and participate in such meetings and conferences (to the
extent permitted by CFIUS).

          7.5 Antitrust Filings. The Purchaser and the Company have filed with the Antitrust
Division of the Justice Department (the “Antitrust Division”) and the Federal Trade
Commission (the “FTC”) the notification and report form required for the transactions
contemplated hereunder by the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the
“HSR Act”), requesting early termination of the waiting period thereunder. Subject to
Section 7.7, the Purchaser and the Company shall respond promptly to inquiries from the
Antitrust Division or the FTC in connection with such filing, including providing any supplemental
information that may be requested by the Antitrust Division or the FTC (except that a Party shall
not be required to respond if doing so would result in, or would reasonably be expected to result
in, a Substantial Detriment to such Party).

          7.6 Avoidance of Impediments. Subject to Section 7.7, each of the Parties
shall use its reasonable best efforts to avoid or eliminate as soon as possible each and every
impediment under any antitrust, competition or other law that may be asserted by the Antitrust
Division or the FTC or any other antitrust, competition or other Governmental Entity so as to
enable the Parties hereto to expeditiously close the transactions contemplated hereby provided that
doing so would not result in a Substantial Detriment with respect to such Party.

- 26 -

 

          7.7 No Substantial Detriment. Notwithstanding anything to the contrary contained in
this Agreement, the Parties hereby agree and acknowledge that no provision contained in this
Section 7 shall require, and the “reasonable best efforts” standard shall not require, or
be construed to require, either Party or any of its respective Subsidiaries or other Affiliates, to
obtain any permits, consents, approvals or authorizations, or any terminations or waivers of any
applicable waiting periods, to propose, negotiate, offer to effect, or consent or commit to, any
procedural or substantive requirements or terms, condition, restrictions, disclosure or taking any
other action that would constitute a Substantial Detriment.

          7.8 CFIUS Filings. The Parties have jointly submitted to CFIUS a draft and a final
voluntary notice relating to the transactions contemplated in this Agreement and the other Pingpong
Transactions pursuant to Exon-Florio. Subject to Section 7.7, but without limiting the
generality of any provisions in this Section 7 or elsewhere in this Agreement in any
respect, the Parties each, to their fullest ability, shall timely provide CFIUS with any additional
or supplemental information requested by CFIUS or its member agencies during the Exon-Florio review
process. Subject to Section 7.7, each of the Parties, in cooperation with each other,
shall take all reasonable steps that they deem advisable, necessary or desirable to finally and
successfully complete the Exon-Florio review process as promptly as practicable. Neither the
Purchaser nor the Company shall be required to agree to any mitigation measure, structural or
conduct remedy or condition suggested or required by CFIUS or any of its member agencies pursuant
to such reviews contemplated by this Section 7.8 that would reasonably be expected to
constitute a Substantial Detriment.

     8. No New Issuances and Registrations. From and after the date that the Purchaser
requests that the Company file a Registration Statement pursuant to the terms of the Investor
Rights Agreement, until such time as the Commission declares the Registration Statement effective,
the Company will not, and it will cause its directors, officers and Affiliates not to, directly or
indirectly, grant, issue, sell, pledge or otherwise dispose of any shares of Common Stock, or
securities convertible into or exchangeable for Common Stock, or file a registration statement with
respect to the registration of any such newly issued shares of Common Stock or other securities.
Notwithstanding the above, the restrictions set forth in this Section 8 shall not apply to
issuances by the Company of (i) securities required to be issued pursuant to contractual
obligations of the Company in effect as of the date hereof; (ii) securities issued on a pro rata
basis to all holders of a class of outstanding equity securities of the Company; (iii) securities
issued in connection with a strategic partnership, licensing, joint venture, collaboration, lending
or other similar arrangements, or in connection with the acquisition or license by the Company of
any business, products or technologies, so long as the aggregate amount of such issuances pursuant
to this clause (iii) does not exceed 10% of the Company’s outstanding capital stock measured as of
the closing of the sale of the Shares, including the Shares; and (iv) equity securities issued
pursuant to employee compensation, incentive, benefit or purchase plans in effect as of the date
hereof or subsequently adopted by the Company’s Board of Directors. Notwithstanding the foregoing,
from and after any such date that the Purchaser requests that the Company file such Registration
Statement until such time that the Commission declares the Registration Statement effective, the
Company shall not, and shall cause its directors, officers and Affiliates not to, sell, offer for
sale or solicit offers to buy any shares of Common Stock or shares of any series of preferred stock
or other securities or instruments convertible into, exchangeable for or otherwise entitling the
holder thereof to acquire shares of Common Stock

- 27 -

 

that would be integrated with the sale of the Shares to the Purchaser for purposes of the Securities Act.

     9. Registration of the Shares; Compliance with the Securities Act.

          9.1 Registration.

          (a) The Company will file with the Commission one or more registration
statements under the Securities Act to register for resale the Shares (collectively
referred to as the “Registration Statement”), and will use its reasonable
best efforts to cause the Registration Statement to be declared effective by the
Commission, all in accordance with, subject to and pursuant to the terms of the
Investor Rights Agreement.

          (b) The Purchaser, at the Company’s sole cost and expense, shall assist the
Company in the Company’s preparation of the Registration Statement and any other
registration statement, prospectus, offering memorandum, current report, periodic
report or any similar or related document to be prepared or filed by the Company in
connection with this Agreement, all in accordance with, subject and pursuant to the
terms of the Investor Rights Agreement.

          9.2 Transfer of Shares in Compliance with Securities Laws. The Purchaser shall not
effect any Transfer of the Shares or any right hereunder to purchase the Shares that would
constitute a sale within the meaning of the Securities Act or pursuant to any applicable state
securities laws, except pursuant to the Registration Statement, in accordance with Rule 144 or as
otherwise permitted by law.

     10. Indemnification. For the purpose of this Section 10, the term
“Purchaser Indemnified Persons” shall mean the Purchaser and each director, officer,
employee, stockholder, agent and representative of the Purchaser and each Person, if any, who
controls the Purchaser within the meaning of the Securities Act or the Exchange Act.

          10.1 Indemnification by the Company. The Company agrees to indemnify and hold
harmless the Purchaser Indemnified Persons, against any losses, claims, damages, liabilities or
expenses, joint or several, to which the Purchaser Indemnified Persons may become subject, under
the Securities Act, the Exchange Act or any other federal or state statutory law or regulation, or
at common law or otherwise (including in settlement of any litigation, if such settlement is
effected with the written consent of the Company), insofar as such losses, claims, damages,
liabilities or expenses (or actions in respect thereof as contemplated below) arise out of or are
based upon (i) any misrepresentation or breach of any representation or warranty made by the
Company in this Agreement or any other certificate, instrument or document contemplated hereby or
thereby, (ii) any breach of any covenant, agreement or obligation of the Company contained in this
Agreement or any other certificate, instrument or document contemplated hereby or thereby (iii) any
cause of action, suit or claim brought or made against such Purchaser Indemnified Person by a third
party (including for these purposes actions against the Purchaser by shareholder(s) of the Company
and derivative actions brought on behalf of the Company) and arising out of or resulting (A) from
the execution,

- 28 -

 

delivery, performance or enforcement of this Agreement or any other certificate,
instrument or document contemplated hereby or thereby, (B) from any transaction financed or to be
financed in whole or in part, directly or indirectly, with the proceeds of the issuance of the
Shares or (C) solely from the status of such Purchaser or holder of the Shares as an investor in
the Company, and the Company will promptly reimburse the Purchaser Indemnified Persons for
reasonable legal and other expenses as such expenses are reasonably incurred by the Purchaser
Indemnified Persons in connection with investigating, defending or preparing to defend, settling,
compromising or paying any such loss, claim, damage, liability, expense or action.

          10.2 Claims for Indemnification. Promptly after receipt by a Purchaser Indemnified
Party under this Section 10 of notice of the threat or commencement of any Action, such
Purchaser Indemnified Party shall, if a claim in respect thereof is to be made against the Company
under this Section 10, promptly notify the Company in writing thereof, but the omission to
notify the Company will not relieve the Company from any liability that it may have to any
Purchaser Indemnified Party for contribution or otherwise under the indemnity agreement contained
in this Section 10 to the extent the Company is not prejudiced as a result of such failure.
In case any such Action is brought against any Purchaser Indemnified Party and such Purchaser
Indemnified Party seeks or intends to seek indemnity from the Company, the Company shall be
entitled to participate in and to assume the defense thereof with counsel reasonably satisfactory
to such Purchaser Indemnified Party; provided, however, if the defendants in any
such action include both the Purchaser Indemnified Party and the Company, and the Purchaser
Indemnified Party shall have reasonably concluded, based on an opinion of counsel reasonably
satisfactory to the Company, that there may be a conflict of interest between the positions of the
Company and the Purchaser Indemnified Party in conducting the defense of any such Action or that
there may be legal defenses available to it that are different from or additional to those
available to the Company, the Purchaser Indemnified Party shall have the right to select separate
counsel to assume such legal defenses and to otherwise participate in the defense of such Action.
Upon receipt of notice from the Company to such Purchaser Indemnified Party of its election to
assume the defense of such Action and approval by the Purchaser Indemnified Party of the counsel,
the Company shall not be liable to such Purchaser Indemnified Party under this Section 10
for any legal or other expenses subsequently incurred by such Purchaser Indemnified Party in
connection with the defense thereof unless (i) the Purchaser Indemnified Party shall have employed
such counsel in connection with the assumption of legal defenses in accordance with the proviso to
the preceding sentence (it being understood, however, that the Company shall not be liable for the
expenses of more than one separate counsel, reasonably satisfactory to the Company, representing
all of the Purchaser Indemnified Parties who are parties to such Action) or (ii) the Company shall
not have employed counsel reasonably satisfactory to the Purchaser Indemnified Party to represent
the Purchaser Indemnified Party within a reasonable time after notice of commencement of Action, in
each of which cases the reasonable fees and expenses of counsel shall be at the expense of the
Company. In no event shall the Company be liable in respect of any amounts paid in settlement of
any Action unless the Company shall have approved in writing the terms of such settlement;
provided that such consent shall not be unreasonably withheld or delayed. The Company
shall not, without the prior written consent of the Purchaser Indemnified Party, effect any
settlement of any pending or threatened proceeding in respect of which any Purchaser Indemnified
Party is or could have been a party and indemnification could have been sought hereunder by such

- 29 -

 

Purchaser Indemnified Party from all liability on claims that are the subject matter of such
proceeding.

     11. Notification. From the date hereof until the Closing, promptly upon, but in any
event no later than five (5) Business Days after, the Company obtaining knowledge of the
institution of, or written threat of, (i) any Action against or affecting the Company, any asset of
the Company or any director or executive officer of the Company (in such capacity) not disclosed to
the Investor as of the date hereof, which action, suit, proceeding or arbitration claims an amount
greater than US$500,000, which could reasonably result in the Company being liable for an amount
greater than US$500,000 or which could reasonably be expected to have a Material Adverse Effect;
(ii) any investigation or proceeding before or by any Governmental Entity, the effect of which is
reasonably likely to have a Material Adverse Effect on the manner in which the Company currently
conducts its business; (iii) any Action affecting the Company or any of its Subsidiaries before any
Government Entity, or the receipt of notice by any such Persons that any of them is a suspect in or
a target of an inquiry or investigation by a Governmental Entity which may result in an indictment
of any of them or the seizure or forfeiture of any of their respective material properties; or (iv)
any Action that challenges or may have the effect of making illegal, preventing, delaying or
otherwise interfering with any of the Pingpong Transactions, the Company shall give written notice
thereof to the Investor and provide such other information (excluding any privileged communications
or information) as may be reasonably available to enable the Investor to evaluate such matters.

     12. Miscellaneous.

          12.1 Amendment and Waiver. Any provision of this Agreement may be amended or waived
if, and only if, such amendment or waiver is in writing and signed, in the case of an amendment, by
the Company and the Purchaser, or, in the case of a waiver, by the Party against whom the waiver is
to be effective. Any amendment or waiver in accordance with this Section 12.1 shall be
binding on the Parties hereto, including all of their successors and permitted assigns and
transferees, even if they do not execute any consent with respect to such amendment or waiver.

          12.2 No Waiver. No waiver of any provision of this Agreement shall be effective
unless set forth in a written instrument signed by the Party waiving such provision. No failure or
delay by a Party in exercising any right, power or remedy under this Agreement shall operate as a
waiver thereof, nor shall any single or partial exercise of any right, power or remedy hereunder
preclude any further exercise thereof or the exercise of any other right, power or remedy. Without
limiting the foregoing, no waiver by a Party of any breach by any other Party of any provision
hereof shall be deemed to be a waiver of a subsequent breach of that or any other provision hereof.

          12.3 Assignment. No Party to this Agreement may, whether by contract, operation of
law or otherwise, assign any of its rights or delegate any of its obligations under this Agreement
without the prior written consent of the other Party, and any purported assignment without such
consent shall be void and without effect.

- 30 -

 

          12.4 Parties in Interest; No Third Party Beneficiaries. This Agreement shall inure to
the benefit of and be binding upon the Parties and their respective successors and permitted
assigns. Nothing in this Agreement, express or implied, is intended to confer upon any Person
other than the Purchaser, the Company, the Purchaser Indemnified Persons or their respective
successors or permitted assigns, any rights or remedies under or by reason of this Agreement.

          12.5 Entire Agreement. This Agreement and the additional agreements and instruments
referenced herein (including those contemplated under the Pingpong Transactions) contain the entire
understanding of the Parties with respect to the subject matters covered herein and therein and
supersede all prior agreements and understandings (whether written or oral) between the Parties
with respect to the subject matters hereof, including, but not limited to, the Transaction Term
Sheet (which shall, upon the execution and delivery hereof, terminate and be rendered null and
void); provided, however, that notwithstanding the foregoing, the terms of the
Confidentiality Agreement shall remain in full force and effect. Except as specifically set forth
herein or therein, no Party makes any representation, warranty, covenant or undertaking with
respect to any such matters. Each Party expressly represents and warrants that it is not relying
on any oral or written representations, warranties, covenants or agreements outside of this
Agreement.

          12.6 Schedules. The inclusion of any matter in any schedule to this Agreement shall
expressly not be deemed to constitute an admission by the Company, or otherwise imply, that any
such matter is material or creates a measure for materiality for the purposes of this Agreement.

          12.7 Counterparts. This Agreement (or any agreement that amends, modifies or
supplements this Agreement) may be executed in any number of counterparts and by the Parties in
separate counterparts, including counterparts transmitted by telecopier or facsimile, each of which
when so executed shall be deemed to be an original and all of which when taken together shall
constitute one and the same agreement.

          12.8 Section Headings. The section and paragraph headings and table of contents
contained in this Agreement are for reference purposes only and shall not in any way affect the
meaning or interpretation of this Agreement.

          12.9 Notices. All notices or other communications required or permitted to be given
under this Agreement shall be in writing in both Chinese and English and shall be deemed to have
been fully given on the date delivered by hand or by a generally recognized courier service (with
relevant fees prepaid), or by other messenger (or, if delivery is refused, upon presentment) or
upon receipt by facsimile transmission (provided, that the confirmation of such facsimile
transmission is delivered by hand or by a generally recognized courier service to the addressee of
the facsimile within five (5) days of the delivery of the facsimile), or upon delivery by
registered or certified mail (return receipt requested), postage prepaid, to the Parties at the
following addresses (or at such other address as such Party may designate by fifteen (15) days’
advance written notice to the other Party given in accordance with this Section 12.9):

          if to the Company, to:

- 31 -

 

ION Geophysical Corporation

2105 CityWest Blvd., Suite 400

Houston, Texas 77042-2839

Attention: David L. Roland, Senior Vice President, 

General Counsel & Corporate Secretary

Facsimile: (281) 879- 3600

          if to the Purchaser, to:

BGP Inc., China National Petroleum Corporation

No. 189, West Fanyang Street,

Zhuo Zhou 072751, Hebei

People’s Republic of China

Attention: Mr. Huasheng Zheng

Facsimile: (+86-10) 8120 1392

     or to such other Persons or addresses as the Person to whom notice is given may have
previously furnished in writing to the party giving such notice in the manner set forth above
(provided that notice of any change of address shall be effective only upon receipt
thereof).

          12.10 Dispute Resolution.

          (a) Each of the Parties hereto agrees that all disputes arising between the
Parties in connection with this Agreement, or the breach, termination,
interpretation or validity thereof, shall be finally settled by the Hong Kong
International Arbitration Centre (the “HKIAC”) pursuant to UNCITRAL Rules
with the Company, on the one hand, being entitled to designate one arbitrator, and
with the Purchaser, on the other hand, being entitled to designate one arbitrator,
while the third arbitrator will be selected by agreement between the two designated
arbitrators or, failing such agreement, within ten (10) calendar days of initial
consultation between the two arbitrators, by the HKIAC pursuant to its arbitration
rules. If either Party fails to designate its arbitrator within twenty (20) calendar
days after the designation of the first of the three arbitrators, the HKIAC shall
have the authority to designate any Person whose interests are neutral to the
Parties as the second of the three arbitrators. The arbitration shall be conducted
in English. To the extent consistent with UNCITRAL Rules, each of the Parties hereto
shall cooperate with the other in provision of information during any discovery
process relating to arbitrations in connection with this Agreement. The Parties
hereto further agree that, to the extent consistent with UNCITRAL Rules, the Parties
shall be entitled to seek temporary and permanent injunctive relief from the
arbitrators without the necessity of proving actual damages and without posting a
bond or other security.

          (b) Each of the Parties hereto agrees that notice may be served upon such Party
at the address and in the manner set forth for such Party in Section 12.9.

- 32 -

 

          (c) To the extent permitted by applicable laws, each of the Parties hereto
hereby unconditionally waives trial by jury in any legal action or proceeding
relating to this Agreement or the transactions contemplated hereby.

          12.11 GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE
WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT GIVING EFFECT TO THE CONFLICT OF LAWS PRINCIPLES
THEREOF.

          12.12 Language. This Agreement and any amendments hereto shall be in Chinese and
English. In the case of any conflict between the Chinese version and the English version of this
Agreement, the English version shall control.

          12.13 Severability. The provisions of this Agreement shall be deemed severable and
the invalidity or unenforceability of any provision shall not affect the validity or enforceability
of the other provisions hereof. If any provision of this Agreement, or the application thereof to
any Person or any circumstance, is found to be invalid or unenforceable: (a) a suitable and
equitable provision shall be substituted therefor in order to carry out, so far as may be valid and
enforceable, the intent and purpose of such invalid or unenforceable provision and (b) the
remainder of this Agreement and the application of such provision to other Persons or circumstances
shall not be affected by such invalidity or unenforceability, nor shall such invalidity or
unenforceability affect the validity or enforceability of such provision, or the application
thereof, in any other jurisdiction.

          12.14 No Strict Construction. The Parties have participated jointly in the
negotiation and drafting of this Agreement. In the event an ambiguity or question of intent or
interpretation arises under any provision of this Agreement, this Agreement shall be construed as
if drafted jointly by the Parties, and no presumption or burden of proof shall arise favoring or
disfavoring either Party by virtue of the authorship of any provision of this Agreement.

          12.15 Survival. Notwithstanding any investigation made by either Party to this
Agreement, all covenants, agreements, representations and warranties made by the Company and the
Purchaser herein shall survive the execution and delivery of this Agreement, the delivery to the
Purchaser of the Shares being purchased and the payment therefor.

          12.16 Fees and Expenses. Except as set forth herein, each of the Company and the
Purchaser shall pay its respective fees and expenses related to the transactions contemplated by
this Agreement.

          12.17 Further Assurances. Each Party agrees to: (a) furnish upon request to each
other such further assurances, information, documents, instruments of transfer or assignment, files
and books and records; (b) promptly execute, acknowledge and deliver any such further assurances,
documents, instruments of transfer or assignment, files and books and records; and (c) do all such
further acts and things as the other Party may reasonably request for the purpose of carrying out
the intent of this Agreement and the documents referred to herein, including any filings and
applications with any Governmental Entity to rescind or modify any initial approvals by such
Governmental Entity.

- 33 -

 

          12.18 Publicity. Unless required by any Governmental Entity or any securities
exchange, no press releases, public announcements or communications with any news media in respect
of this Agreement or the purchase and sale of the Shares contemplated hereby shall be made by
either Party without the prior written consent of the other Party. The Parties shall (i) consult
with each other prior to making any required press releases or public announcements or public
filings with any Governmental Entity or with any securities exchange with respect to the purchase
and sale of the Shares contemplated hereby and (ii) cooperate as to the timing and contents of any
press release, public announcement or communication with news media in respect of this Agreement or
the purchase and sale of the Shares contemplated hereby.

[Remainder of Page Left Intentionally Blank]

- 34 -

 

     IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their duly
authorized representatives as of the day and year first above written.

	 	 	 	 	 
	 	ION GEOPHYSICAL CORPORATION

 	 
	 	By:  	\s\ David L. Roland
 	 
	 	 	Name:  	David L. Roland 	 
	 	 	Title:  	Senior Vice President and General Counsel 	 
	 
	 	BGP INC., CHINA NATIONAL PETROLEUM 

CORPORATION

 	 
	 	By:  	\s\ Wang Tiejun
 	 
	 	 	Name:  	Wang Tiejun 	 
	 	 	Title:  	President and Executive Director 	 
	 

- 35 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00171-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00171-of-00352.parquet"}]]